{"gene":"KCNJ2","run_date":"2026-06-10T02:59:49","timeline":{"discoveries":[{"year":2001,"finding":"Loss-of-function mutations in KCNJ2 (Kir2.1) cause Andersen's syndrome. Expression of D71V and other mutations in Xenopus oocytes revealed loss of function and a dominant-negative effect on Kir2.1 current by voltage-clamp, establishing KCNJ2 as the causative gene.","method":"Xenopus oocyte expression system, two-electrode voltage-clamp, genetic mapping","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct functional assay (voltage-clamp) with multiple mutations, replicated across subsequent studies","pmids":["11371347"],"is_preprint":false},{"year":2002,"finding":"Ten KCNJ2 mutations associated with Andersen syndrome all resulted in loss of function and dominant-negative suppression of Kir2.1 channel function when assessed by two-microelectrode voltage-clamp in Xenopus oocytes. Computer simulation showed reduced Kir2.1 prolongs terminal action potential phase and, at low extracellular K+, induces Na+/Ca2+ exchanger-dependent delayed afterdepolarizations.","method":"Two-microelectrode voltage-clamp (Xenopus oocytes), ventricular myocyte computational modeling","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro functional assay across 10 mutations with mechanistic modeling, replicated dominant-negative mechanism","pmids":["12163457"],"is_preprint":false},{"year":2002,"finding":"The R67W KCNJ2 mutation demonstrates loss of function and a dominant-negative effect on Kir2.1 current, establishing that Kir2.1 plays roles in both cardiac/skeletal muscle excitability and developmental signaling.","method":"Biophysical characterization by voltage-clamp in Xenopus oocytes","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional voltage-clamp assay, single lab, consistent with replicated dominant-negative mechanism","pmids":["12148092"],"is_preprint":false},{"year":2003,"finding":"Different Andersen-Tawil syndrome KCNJ2 mutations cause channel dysfunction via distinct mechanisms: (1) some mutants co-assemble with wild-type at the membrane and exert dominant-negative effects; (2) V302M mutant loses co-assembly ability with wild-type and fails to traffic to the cell surface; (3) deletion mutants (Δ95-98, Δ314-315) fail to traffic to the membrane but retain co-assembly with wild-type, causing haplo-insufficiency.","method":"Heterologous expression in HEK293 cells, whole-cell patch-clamp, confocal fluorescence microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (electrophysiology + imaging), multiple mutations tested, mechanistically distinguishes trafficking vs. dominant-negative mechanisms","pmids":["14522976"],"is_preprint":false},{"year":2003,"finding":"Filamin-A directly interacts with Kir2.1 via the Kir2.1 carboxyl terminus. This interaction increases the number of functional Kir2.1 channels at the plasma membrane without altering single-channel properties.","method":"Yeast two-hybrid screen, GST pulldown overlay assay, co-immunoprecipitation from arterial smooth muscle lysates, immunocytochemistry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal pulldown/co-IP, yeast two-hybrid, and colocalization with functional readout, multiple orthogonal methods in one study","pmids":["12923176"],"is_preprint":false},{"year":2005,"finding":"Crystal structures of the cytoplasmic domains of Kir2.1 and Kir3.1 show a G-loop that forms a diffusion barrier between cytoplasmic and transmembrane pores. G-loop mutations disrupted gating or inward rectification. A di-aspartate cluster at the distal cytoplasmic pore of Kir2.1 modulates inward rectification.","method":"X-ray crystallography, site-directed mutagenesis, electrophysiology","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with mutagenesis and functional validation in a single study","pmids":["15723059"],"is_preprint":false},{"year":2005,"finding":"The KCNJ2 D172N mutation causes a gain-of-function in Kir2.1 (SQT3): larger outward IK1 at potentials between -75 mV and -45 mV with a shifted peak current, due to altered inward rectification. This gain-of-function accelerates final repolarization, shortens action potential duration, and predicts steeper restitution favoring re-entrant arrhythmias.","method":"Whole-cell patch-clamp (heterologous expression), computational modeling of human ventricular myocyte","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro electrophysiology plus computational modeling, mechanism confirmed by subsequent replication","pmids":["15761194"],"is_preprint":false},{"year":2005,"finding":"A Kir2.1 gain-of-function mutation (V93I) is associated with familial atrial fibrillation, demonstrating that increased Kir2.1 channel activity (opposed to ATS loss-of-function) can promote AF.","method":"Genetic screening, functional analysis by patch-clamp in heterologous expression system","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, single functional assay method; gain-of-function direction consistent with mechanism","pmids":["15922306"],"is_preprint":false},{"year":2005,"finding":"Kir2.1 preferentially exports from the Golgi to the plasma membrane via a tyrosine-dependent YXXPhi motif in its C-terminus (20-amino acid stretch). This dominant Golgi export signal controls the stoichiometry of Kir2.x heteromers at the cell surface.","method":"Chimeric channel construction, functional expression in oocytes and mammalian cells, subcellular trafficking analysis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — chimera/mutagenesis approach with functional readout and trafficking analysis, identifies specific motif mechanism","pmids":["15827083"],"is_preprint":false},{"year":2000,"finding":"Kir2.1 gene expression in arterial smooth muscle is required for inward rectifier K+ currents and K+-induced vasodilation in cerebral arteries. Kir2.1 knockout mice lack these Kir currents and K+-induced dilatory response.","method":"Targeted gene disruption (Kir2.1-/- mice), patch-clamp of isolated cerebral artery myocytes, pressurized cerebral artery dilation assay","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with specific physiological phenotype, direct functional assay confirming absence of Kir current","pmids":["10904001"],"is_preprint":false},{"year":1994,"finding":"Kir2.1 (IRK1) channel activity requires both PKA-mediated phosphorylation and ATP hydrolysis (via an ATPase-like mechanism). PKA increases current amplitude only when channels are also stimulated by Mg-ATP/Mg2+, while PKC activation down-regulates Kir2.1 currents, showing opposing regulation by these kinases.","method":"Giant inside-out patches from Xenopus oocytes, pharmacological manipulation of PKA, PKC, ATP analogs","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro biochemical reconstitution approach with multiple pharmacological probes, mechanistically defines dual requirement","pmids":["7993632"],"is_preprint":false},{"year":1994,"finding":"Kir2.1 (IRK1) intrinsic gating depends on voltage, external K+ concentration, and intracellular Mg2+. Removal of intracellular Mg2+ permits brief outward currents at depolarization, demonstrating that Mg2+ is required for voltage-dependent gating/rectification.","method":"Stable expression in MEL cells, whole-cell and single-channel recording, Mg2+ manipulation","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiological characterization with defined ionic conditions, foundational mechanism paper","pmids":["8189383"],"is_preprint":false},{"year":1996,"finding":"PKA directly phosphorylates Kir2.1 (IRK1) at a C-terminal site (S425), mediating inhibition following serotonin 5-HT1A receptor activation via cAMP elevation. Mutant IRK1(S425N) lacking this PKA phosphorylation site is not inhibited by PKA.","method":"Whole-cell patch-clamp in COS-7 cells, pharmacological cAMP elevation, site-directed mutagenesis (S425N), receptor coexpression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis identifies specific phosphorylation site, receptor coexpression links signaling pathway to channel inhibition","pmids":["8650176"],"is_preprint":false},{"year":1996,"finding":"m1 muscarinic receptor stimulation inhibits Kir2.1 (IRK1) current via PKC activation. m2 receptor stimulation does not affect Kir2.1. PKC activator phorbol ester mimics m1 inhibition, and PKC inhibitors (staurosporine, calphostin C) prevent it. cAMP and intracellular Ca2+ are not involved.","method":"Whole-cell patch-clamp in tsA cells, receptor coexpression, pharmacological PKC manipulation","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct pharmacological dissection of signaling pathway with receptor selectivity controls, clear mechanistic conclusion","pmids":["8609894"],"is_preprint":false},{"year":1998,"finding":"Tyrosine kinase phosphorylation directly suppresses Kir2.1 channel activity. The Y242 residue in the C-terminal domain is a direct TK substrate; Y242F mutant channels are insensitive to TK-mediated suppression. NGF, EGF, and insulin each suppress Kir2.1 activity via this mechanism.","method":"Patch-clamp in tsA-201 cells and Xenopus oocytes, site-directed mutagenesis (Y242F), receptor coexpression, pharmacological TK/PTP manipulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis identifies specific phosphorylation residue, multiple growth factor receptors tested, direct substrate demonstration","pmids":["9852063"],"is_preprint":false},{"year":2001,"finding":"AKAP79 directly associates with the Kir2.1 channel via both N- and C-terminal intracellular domains (demonstrated by GST pulldown and co-immunoprecipitation), and enhances Kir2.1 response to elevated intracellular cAMP, suggesting AKAP79 anchors PKA near Kir2.1 phosphorylation sites.","method":"Co-immunoprecipitation, GST pulldown from cell lysates, whole-cell patch-clamp with cAMP stimulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal pulldown and co-IP with functional electrophysiological validation, two orthogonal methods","pmids":["11287423"],"is_preprint":false},{"year":2001,"finding":"Kir5.1 (KCNJ16) co-localizes with Kir2.1 in brain and kidney and forms electrically silent heteromeric channels with Kir2.1 when coexpressed in Xenopus oocytes, thereby negatively regulating Kir2.1 channel activity.","method":"Xenopus oocyte expression, two-electrode voltage-clamp, in situ hybridization, chromosomal mapping","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional co-expression assay demonstrating heteromerization, single lab, limited mechanistic follow-up","pmids":["11240146"],"is_preprint":false},{"year":2002,"finding":"Kir2.1 exhibits transverse tubular localization in ventricular cardiomyocytes (89% of cells) but less so in atrial cells (26%). Kir2.3 is strongly expressed at intercalated disks. These differential subcellular distributions contribute to the >10-fold larger IK1 in ventricle vs. atrium.","method":"Western blot, immunocytochemistry, patch-clamp electrophysiology in isolated canine cardiomyocytes","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by immunocytochemistry with functional correlation, two orthogonal methods","pmids":["12181143"],"is_preprint":false},{"year":2002,"finding":"Kir2.4 co-assembles with Kir2.1 to form functional heterotetrameric channels with properties distinct from either homomeric channel (greater Ba2+ sensitivity). Physical co-assembly confirmed by His-tag pulldown.","method":"Co-expression in Xenopus oocytes and COS-7 cells, dominant-negative suppression, His-tag pulldown/Western blot, tandem subunit expression","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-assembly confirmed by pulldown plus functional characterization via multiple methods","pmids":["12381809"],"is_preprint":false},{"year":2003,"finding":"The G215D Kir2.1 mutant (Andersen syndrome) traffics normally to the plasma membrane, co-assembles with wild-type Kir2.1 into hetero-multimers (demonstrated by FRET), and exerts dominant-negative suppression of both inward and outward currents without trafficking defect.","method":"Whole-cell patch-clamp in COS7 cells, confocal microscopy with YFP/CFP-tagged channels, FRET analysis","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET demonstrates physical interaction, electrophysiology confirms functional dominant-negative effect, two orthogonal methods single lab","pmids":["12689820"],"is_preprint":false},{"year":2004,"finding":"Cholesterol increase suppresses Kir2.1 whole-cell current in null cell lines by promoting transition of channels between active and silent states, without altering total protein levels, surface expression, unitary conductance, or open probability significantly. Kir2.x channels partition almost exclusively into cholesterol-rich lipid rafts (Triton-insoluble fractions).","method":"Whole-cell patch-clamp, cholesterol manipulation, single-channel recording, Western blot, cell surface biotinylation, lipid raft fractionation","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods (electrophysiology, surface expression, raft fractionation), mechanistic conclusions about active/silent state transition","pmids":["15465867"],"is_preprint":false},{"year":2005,"finding":"The KCNJ2 T192A mutation, located in the PIP2-binding site and Kir2.1 multimerization region, produces a non-functional channel and weak dominant-negative effect, implicating T192 as important for both PIP2 interaction and channel assembly.","method":"Xenopus oocyte expression system, voltage-clamp","journal":"Circulation","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct functional assay establishing role of specific residue in PIP2 binding/multimerization, single lab single method","pmids":["12045162"],"is_preprint":false},{"year":2006,"finding":"The V302M mutation in the Kir2.1 G-loop specifically abolishes K+ conduction without altering subunit assembly or surface expression. The V302 side chain is critical for G-loop potassium conduction and PIP2 gating. Amino acid substitution analysis shows channel activity and PIP2 sensitivity are highly sensitive to the size, shape, and hydrophobicity at position 302.","method":"Site-directed mutagenesis, heterologous expression, patch-clamp, cell surface expression assay, crystal structure interpretation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with crystal structure-guided analysis and functional validation, mechanistically defines G-loop gating role","pmids":["17166852"],"is_preprint":false},{"year":2007,"finding":"miR-1 post-transcriptionally represses KCNJ2 (Kir2.1) and GJA1 (connexin 43), causing membrane depolarization and slowed conduction. miR-1 overexpression in infarcted rat hearts exacerbates arrhythmogenesis, while antisense inhibitor of miR-1 relieves arrhythmogenesis.","method":"miRNA overexpression and antisense inhibition in rat hearts, electrophysiology, molecular target validation","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo gain- and loss-of-function with defined electrophysiological phenotype, widely replicated post-transcriptional regulation mechanism","pmids":["17401374"],"is_preprint":false},{"year":2008,"finding":"Kir2.1 is degraded via the lysosomal pathway. Lysosomal inhibitors (NH4Cl, chloroquine, leupeptin) increase steady-state Kir2.1 protein levels and plasma membrane-originating inward rectifier current densities without altering current-voltage characteristics, establishing lysosomes as a major Kir2.1 degradation route.","method":"Lysosomal inhibitor treatment, Western blot, patch-clamp electrophysiology, confocal microscopy","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — three different lysosomal inhibitors with consistent protein and functional results, two orthogonal methods","pmids":["18182162"],"is_preprint":false},{"year":2009,"finding":"KCNJ2 V227F mutation causes a latent loss-of-function phenotype dependent on PKA-mediated phosphorylation at S425. Under basal conditions, V227F coexpressed with wild-type produces normal IK1, but PKA stimulation markedly reduces outward IK1. The S425N phosphorylation-null mutation eliminates PKA-induced reduction.","method":"Heterologous expression in COS-1 cells, whole-cell voltage-clamp, PKA-stimulating cocktail (forskolin/IBMX), site-directed mutagenesis (S425N)","journal":"Circulation. Arrhythmia and electrophysiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis identifies specific phosphorylation site as required for phenotype, direct functional assay","pmids":["19843922"],"is_preprint":false},{"year":2011,"finding":"AMPK inhibits Kir2.1 by reducing channel protein abundance at the plasma membrane. This effect is partially mediated through AMPK phosphorylation of the ubiquitin ligase Nedd4-2; Nedd4-2(S795A) lacking the AMPK phosphorylation site is not augmented by AMPK, though wild-type Nedd4-2 alone also downregulates Kir2.1 currents.","method":"Xenopus oocyte co-expression, two-electrode voltage-clamp, confocal imaging of membrane protein abundance, mutagenesis of AMPK phosphorylation site on Nedd4-2","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay with mutagenesis defining Nedd4-2 phosphorylation site, two methods in single lab","pmids":["21501591"],"is_preprint":false},{"year":2013,"finding":"E299V KCNJ2 mutation causes gain-of-function with loss of inward rectification, generating a large abnormal outward IK1. Co-immunoprecipitation and kinetic analysis showed E299V and wild-type isoforms heteromerize, impairing function. Homomeric E299V results in gain-of-function.","method":"Whole-cell patch-clamp, co-immunoprecipitation, kinetic analysis, computational modeling","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — electrophysiology plus co-IP to demonstrate heteromerization, computational modeling validates phenotype, multiple orthogonal methods","pmids":["23440193"],"is_preprint":false},{"year":2013,"finding":"ESCRT (endosomal sorting complex required for transport) and ERAD (ER-associated degradation) both mediate Kir2.1 degradation in human cells, with ESCRT playing a more prominent role in controlling Kir2.1 surface expression.","method":"Yeast genetic screen (synthetic gene array), heterologous expression in human cells, loss-of-function of ESCRT/ERAD pathway components","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide screen plus validation in human cells, two degradation systems identified with orthogonal approaches","pmids":["24227888"],"is_preprint":false},{"year":2014,"finding":"A Kir2.1 gain-of-function mutation (M301K) causes loss of inward rectification in a charge-dependent manner. Homozygous M301K is non-functional, but heterozygous coexpression with wild-type yields larger outward currents above -30 mV. Neutral substitutions (M301A) show normal rectification, establishing that the positive charge at M301 specifically impairs rectification.","method":"Heterologous expression in mammalian cells, whole-cell patch-clamp, site-directed mutagenesis (M301K/R/A), neonatal rat ventricular myocyte overexpression","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with charge manipulation identifies specific mechanism, functional validation in cardiomyocytes","pmids":["22155372"],"is_preprint":false},{"year":2014,"finding":"An SQT3-associated Kir2.1 mutation enhances channel surface expression and stability by reducing ubiquitylation and proteasomal degradation, alters protein partitioning in lipid rafts (shifting to cholesterol-poor domains), and reduces interaction with caveolin-2. Wild-type Kir2.1 binds both caveolin-1 and caveolin-2 and is degraded via the ubiquitin-proteasome pathway.","method":"Surface expression assay, ubiquitylation assay, lipid raft fractionation, co-immunoprecipitation, patch-clamp","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ubiquitylation, raft fractionation, co-IP, electrophysiology) in a single study identifying novel regulatory mechanisms","pmids":["24794859"],"is_preprint":false},{"year":2018,"finding":"Kir2.1 and Nav1.5 pre-assemble early in the forward trafficking pathway (at the trans-Golgi, via AP1 adaptor complex) and traffic together to common membrane microdomains. Trafficking-deficient Kir2.1 mutants reduce Nav1.5 surface expression; FRAP shows coexpression increases cytoplasmic mobility of both channels. AP1 co-localizes with and co-immunoprecipitates with both channels; Nav1.5 interacts with AP1 through Y1810.","method":"Patch-clamp, cell surface biotinylation, glycosylation analysis, FRAP, viral gene transfer in cardiomyocytes, co-immunoprecipitation, site-directed mutagenesis (Nav1.5Y1810), immunostaining, AP1 subunit silencing in hiPSC-CMs","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-IP, FRAP, biotinylation, mutagenesis, gene silencing) in heterologous and primary cell systems","pmids":["29514831"],"is_preprint":false},{"year":2017,"finding":"In Kir2.1-Nav1.5 complexes, CaMKII inhibition decreases both INa and IK1 only when channels are coexpressed (not Kir2.1 alone), indicating the complex is a CaMKII substrate. 14-3-3 protein inhibition reduces currents from complexes but not individual channels. Dynamin-dependent endocytosis reduces Kir2.1 internalization but not Nav1.5 or the Kir2.1-Nav1.5 complex. The Kir2.1-Nav1.5 complex is degraded via Nedd4-2/proteasome pathway (like Nav1.5, not like Kir2.1 alone).","method":"Proximity ligation assay, patch-clamp, intracellular antibody dialysis, pharmacological inhibitors, co-immunoprecipitation","journal":"Frontiers in physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods defining complex-specific regulation distinct from individual channel biology","pmids":["29184507"],"is_preprint":false},{"year":2018,"finding":"Brugada syndrome-associated Nav1.5 trafficking-defective mutants decrease IK1 by failing to positively modulate Kir2.1/Kir2.2 channels. Golgi trafficking-defective Nav1.5 mutants additionally exert dominant-negative effects on Kir2.1/Kir2.2 and trap them, further reducing IK1. Conversely, ER trafficking-defective Nav1.5 can be partially rescued by Kir2.1/Kir2.2 via an unconventional GRASP-dependent secretory route.","method":"Mouse SCN5A haploinsufficiency models, heterologous expression, hiPSC-CM experiments, patch-clamp, immunostaining","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple model systems (mouse KO, heterologous cells, hiPSC-CMs), bidirectional trafficking relationship established","pmids":["30232268"],"is_preprint":false},{"year":2018,"finding":"Kir2.1 promotes gastric cancer invasion and metastasis via a non-ion-conducting mechanism: it interacts with Stk38 kinase (confirmed by co-IP) to inhibit Smurf1-mediated ubiquitination and degradation of MEKK2, thereby activating the MEK1/2-ERK1/2-Snail pathway promoting EMT.","method":"Co-immunoprecipitation, siRNA knockdown, overexpression, invasion/metastasis assays, ubiquitination assay, signaling pathway inhibitors","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP identifies Stk38 interaction, signaling pathway mechanistically validated, single lab","pmids":["29549164"],"is_preprint":false},{"year":2016,"finding":"Kir2.1 function is required in cranial neural crest for craniofacial morphogenesis. In Xenopus, ATS-associated KCNJ2 mutations alter membrane voltage regionalization in ectoderm during neurulation and disrupt expression of craniofacial patterning genes. Optogenetic membrane potential manipulation in ectoderm during early neurulation is sufficient to cause craniofacial anomalies, identifying a bioelectric mechanism.","method":"Xenopus microinjection, optogenetics, voltage-sensitive dye imaging, in situ hybridization/immunostaining for patterning genes, Kcnj2KO mouse analysis","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — optogenetics with spatial and temporal control, multiple ATS mutations, KO mouse validation, multiple orthogonal approaches","pmids":["26864374"],"is_preprint":false},{"year":2018,"finding":"Kir2.1 is required in cranial neural crest for palatal shelf proliferation and closure. Loss of Kir2.1 reduces BMP signaling efficacy (decreased phospho-Smad 1/5/8 and BMP target expression Smad6, Satb2) without altering BMP ligand, receptor, or Smad levels. Cdo forms a complex with Kir2.1 to promote surface expression during myogenic differentiation.","method":"Kcnj2 KO mice, conditional neural crest-specific knockout, BMP signaling analysis (Western blot for phospho-Smad), proliferation assays","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined signaling phenotype, multiple BMP pathway readouts, single lab","pmids":["29571612"],"is_preprint":false},{"year":2016,"finding":"Cdo forms a protein complex with Kir2.1 during myogenic differentiation and promotes Kir2.1 surface expression via p38MAPK signaling. Cdo depletion reduces Kir2.1 surface expression and channel activity; constitutively active MKK6(EE) rescues Kir2.1 activity in Cdo-depleted cells.","method":"Co-immunoprecipitation, surface expression assay, patch-clamp, siRNA knockdown, MKK6(EE) rescue, Cdo-/- primary myoblasts","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, functional rescue, and primary cell validation, multiple orthogonal approaches, single lab","pmids":["27380411"],"is_preprint":false},{"year":2022,"finding":"Kir2.1-mediated membrane hyperpolarization controls macrophage nutrient acquisition by supporting cell-surface retention of nutrient transporters (4F2hc, GLUT1) through modulation of plasma membrane phospholipid dynamics. Loss of Kir2.1 induces caloric restriction state, activates AMPK and GCN2, depletes epigenetic substrates for histone methylation, and suppresses transcription of metabolism-responsive inflammatory genes.","method":"Genetic knockdown/knockout, pharmacological channel blockade, nutrient uptake assays, Ca2+ imaging, lipid/phospholipid analysis, epigenetic analysis, in vivo sepsis model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (genetic, pharmacological, metabolic, epigenetic), in vitro and in vivo validation, mechanistic pathway defined","pmids":["35729093"],"is_preprint":false},{"year":2013,"finding":"Lysosome-mediated and ESCRT-mediated degradation control Kir2.1 surface levels; select α-arrestins (Ldb19/Art1, Aly1/Art6, Aly2/Art3) promote Kir2.1 trafficking to the cell surface and increase its activity via Rsp5 ubiquitin ligase and calcineurin effectors.","method":"Yeast synthetic gene array screen, fluorogen-activating protein fusion for surface quantification, functional complementation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide screen plus functional validation with novel surface quantification tool, single lab","pmids":["29784874"],"is_preprint":false},{"year":2012,"finding":"SGK3 (serum/glucocorticoid-inducible kinase 3) upregulates Kir2.1-mediated currents and increases Kir2.1 protein abundance at the plasma membrane by promoting channel insertion (not reducing retrieval), as shown by similar brefeldin A-induced current decay with or without SGK3.","method":"Xenopus oocyte co-expression, two-electrode voltage-clamp, confocal imaging of membrane protein, brefeldin A trafficking assay","journal":"The Journal of membrane biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct functional and surface expression assay, mechanism of insertion identified, single lab","pmids":["23188060"],"is_preprint":false},{"year":2022,"finding":"Kir2.1 channel regulates macrophage M1 polarization via a Ca2+/CaMKII/ERK/NF-κB signaling pathway: Kir2.1-mediated membrane hyperpolarization drives Ca2+ influx, activating CaMKII/ERK/NF-κB; blocking Kir2.1 or high extracellular K+ suppresses M1 polarization and protects mice from LPS-induced peritonitis.","method":"siRNA knockdown, pharmacological blockade (ML133), Ca2+ imaging, Western blot for p-CaMKII/p-ERK/p-NF-κB, in vivo peritonitis model","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Ca2+ imaging links hyperpolarization to Ca2+ influx, signaling pathway validated biochemically, in vivo confirmation","pmids":["35694964"],"is_preprint":false},{"year":1996,"finding":"Polyamine-induced rectification of Kir2.1 (IRK1) depends strongly on external K+ concentration (not internal K+): increasing external K+ speeds activation kinetics and shifts rectification proportional to EK shift. This establishes that permeant K+ ions modulate polyamine block kinetics in a long, narrow pore with multiple binding sites.","method":"Patch-clamp of Kir2.1-expressing Xenopus oocytes, varied internal and external K+ concentrations, polyamine block kinetics analysis","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic biophysical characterization, multiple polyamines and K+ concentrations tested, foundational mechanistic paper","pmids":["8854340"],"is_preprint":false},{"year":2015,"finding":"Kir2.1 in endothelial cells (ECs) of mesenteric arteries amplifies endothelium-dependent vasodilatation. EC-specific Kir2.1 knockdown mice show reduced K+-induced and agonist/IK/SK-induced vasodilatations. The Kir channel blocker Ba2+ does not affect TRPV4, IK, or SK channel currents, establishing Kir2.1 as a downstream booster of the vasodilatory signal.","method":"EC-specific Kir2.1 conditional KO mice, patch-clamp, pressurized artery myography, pharmacological channel blockers","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple vasodilatory stimuli tested, pharmacological and genetic tools, clear pathway position established","pmids":["26840527"],"is_preprint":false},{"year":2007,"finding":"Beta3-adrenoceptor activation increases Kir2.1 currents via PKC-dependent signaling (not PKA or CaMKII), while Kir2.2 is activated via PKA. This receptor-subtype-specific kinase pathway selectivity was established by kinase inhibitors and comparison of Kir2.2 mutants lacking PKC sites.","method":"Xenopus oocyte coexpression with human beta3-AR, two-electrode voltage-clamp, pharmacological kinase inhibitors, Kir2.2 PKC-site mutants","journal":"Naunyn-Schmiedeberg's archives of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic pharmacological dissection with receptor specificity controls, mutagenesis confirms Kir2.2 PKC site non-involvement, single lab","pmids":["17534603"],"is_preprint":false},{"year":2013,"finding":"Zacopride selectively activates Kir2.1 homomeric channels via a PKA-dependent pathway in HEK293 cells. It does not affect Kir2.2 or Kir2.3 homomeric channels or Kir2.x heteromers. The effect is abolished by PKA inhibition and by the S425L mutation at the PKA phosphorylation site.","method":"Whole-cell patch-clamp in HEK293 cells transfected with Kir2.x, PKA inhibition, S425L mutagenesis","journal":"Science China. Life sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — mutagenesis of phosphorylation site and pharmacological inhibition define mechanism, single lab","pmids":["23929001"],"is_preprint":false},{"year":2002,"finding":"Activated Ras (Ras-L61) reduces Kir2.1 (IRK1) current density by delocalizing the channel from the plasma membrane to the cytoplasm via the MAPK pathway; MEK inhibitor PD98059 restores membrane localization and current. This establishes Ras-MAPK pathway as a regulator of Kir2.1 subcellular localization.","method":"Heterologous expression in HEK293 cells, patch-clamp, confocal microscopy of GFP-IRK1, Northern blot, MEK inhibitor treatment","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional and localization data with pharmacological rescue, two orthogonal methods, single lab","pmids":["11809752"],"is_preprint":false},{"year":2015,"finding":"KCNJ2/Kir2.1 promotes multidrug resistance in small-cell lung cancer by interacting with MRP1/ABCC1 (confirmed by co-IP) and is regulated by the Ras/MAPK pathway and miR-7.","method":"Co-immunoprecipitation, shRNA knockdown, overexpression, cell growth/apoptosis/drug resistance assays","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — co-IP identifies MRP1 interaction, functional consequences shown, but single lab and limited mechanistic follow-up of the interaction","pmids":["25880778"],"is_preprint":false},{"year":1997,"finding":"Arg148 in the H5 pore domain of Kir2.1 (IRK1) serves as an external barrier for cationic blockers. Coexpression of R148H mutant with wild-type creates heteromeric channels with altered permeability ratios, increased Mg2+/Ca2+ sensitivity, and changed blocking kinetics. The R148 charge controls access of Mg2+ and Ca2+ to the electric field of the pore.","method":"Mutagenesis (R148H), Xenopus oocyte coexpression, single-channel recording, ion selectivity measurements, cation block analysis","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic mutagenesis with quantitative biophysical analysis of blocking kinetics, single-channel resolution","pmids":["9382895"],"is_preprint":false},{"year":2016,"finding":"Kir2.1 inhibition in spinal microglia depolarizes their resting membrane potential, reduces proliferation after nerve injury, and attenuates neuropathic pain behaviors. Kir2.1 protein expression is increased at the plasma membrane of spinal microglia 2 days post-nerve injury, coinciding with peak proliferation.","method":"Patch-clamp, siRNA knockdown, ML133 pharmacological blockade, intrathecal injection in spared nerve injury model, immunofluorescence","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological inhibition with in vitro and in vivo phenotype, surface expression confirmed, single lab","pmids":["32220118"],"is_preprint":false},{"year":2024,"finding":"KCNJ2 inhibition potently mitigates neurodegenerative processes (neuronal death, tau phosphorylation, TDP-43 nuclear egress) after mechanical brain injury in iPSC-derived cortical organoids and in vivo, identified through genome-wide CRISPR interference screening.","method":"Genome-wide CRISPRi screen, iPSC-derived cortical organoids, ultrasound mechanical injury model, in vivo validation","journal":"Cell stem cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — unbiased genome-wide screen with in vitro and in vivo validation across multiple TBI hallmarks, single lab","pmids":["38579683"],"is_preprint":false},{"year":1998,"finding":"The KCNJ2 promoter contains a minimal 172 bp TATA-less element driven by Sp1, Sp3, and NF-Y transcription factors at E box, Y box, and GC box elements. Upstream sequences restrict expression in a cell-type-dependent manner, identifying tissue-selective repressor elements.","method":"Promoter deletion analysis, transfection reporter assays, transcription factor co-transfection in cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic deletion analysis with transcription factor identification, two orthogonal methods, establishes minimal promoter mechanism","pmids":["9712915"],"is_preprint":false}],"current_model":"KCNJ2/Kir2.1 is a strong inwardly rectifying K+ channel that forms homotetramers or heterotetramers with Kir2.2, Kir2.3, Kir2.4, or Kir5.1; its inward rectification is mediated by voltage-dependent block of the cytoplasmic pore by Mg2+ and polyamines (especially spermine), with the G-loop and di-aspartate cluster as structural determinants; channel gating and surface expression are regulated by PIP2 binding, PKA phosphorylation (at S425), PKC, tyrosine kinase phosphorylation (at Y242), AMPK (via Nedd4-2), PKB/PIKfyve, SGK3, and cholesterol/lipid raft partitioning; Kir2.1 is trafficked to the plasma membrane via a Golgi export YXXPhi motif, promoted by filamin-A and α-arrestins, and degraded via lysosomal and ESCRT pathways; in cardiomyocytes, Kir2.1 co-assembles with Nav1.5 early in the secretory pathway via AP1 adaptor, forming macromolecular complexes with distinct regulatory properties including CaMKII-dependent modulation; loss-of-function mutations cause Andersen-Tawil syndrome through dominant-negative or trafficking-defective mechanisms, while gain-of-function mutations cause Short QT Syndrome type 3; the channel also controls bioelectric membrane potential in macrophages (regulating inflammation via Ca2+/CaMKII/ERK/NF-κB) and in developing craniofacial ectoderm, and mediates K+-induced vasodilation in arterial smooth muscle and endothelium."},"narrative":{"mechanistic_narrative":"KCNJ2 encodes Kir2.1, a strong inwardly rectifying potassium channel that sets resting membrane potential and shapes the terminal repolarization phase of the cardiac action potential, with broader roles in vascular tone, development, and immune cell function [PMID:11371347, PMID:12163457, PMID:10904001]. Inward rectification is an intrinsic biophysical property requiring intracellular Mg2+ and voltage-dependent polyamine block within a long, narrow pore whose kinetics depend on permeant external K+; the H5 pore residue Arg148 controls cationic blocker access, while a cytoplasmic G-loop diffusion barrier and a distal di-aspartate cluster are structural determinants of rectification [PMID:15723059, PMID:8189383, PMID:8854340, PMID:9382895]. Channel gating and surface density are heavily regulated: PKA phosphorylation at S425 and PKC, tyrosine-kinase phosphorylation at Y242, AMPK (acting through Nedd4-2), SGK3, and cholesterol/lipid-raft partitioning all tune Kir2.1 activity and abundance [PMID:7993632, PMID:8650176, PMID:8609894, PMID:9852063, PMID:15465867, PMID:21501591, PMID:23188060]. Forward trafficking proceeds through a C-terminal tyrosine-based YxxΦ Golgi-export motif and is promoted by filamin-A and α-arrestins, while degradation occurs via lysosomal, ESCRT, ERAD, and ubiquitin-proteasome routes [PMID:12923176, PMID:15827083, PMID:24227888, PMID:29784874]. In cardiomyocytes Kir2.1 pre-assembles with the sodium channel Nav1.5 at the trans-Golgi through the AP1 adaptor, forming a reciprocally trafficked macromolecular complex with distinct CaMKII- and 14-3-3-dependent regulation and Nedd4-2-mediated degradation [PMID:29514831, PMID:29184507, PMID:30232268]. Loss-of-function KCNJ2 mutations cause Andersen-Tawil syndrome through dominant-negative co-assembly or trafficking-defective haploinsufficiency, whereas gain-of-function mutations that abolish inward rectification cause short QT syndrome type 3 and familial atrial fibrillation [PMID:11371347, PMID:14522976, PMID:15761194, PMID:15922306, PMID:23440193, PMID:22155372]. Beyond excitable tissue, Kir2.1 controls bioelectric membrane potential governing craniofacial neural-crest morphogenesis and BMP signaling, K+-induced vasodilation in arterial smooth muscle and endothelium, macrophage polarization and nutrient acquisition, and through non-conducting interactions promotes cancer invasion and drug resistance [PMID:26864374, PMID:29571612, PMID:35729093, PMID:35694964, PMID:26840527, PMID:29549164, PMID:25880778].","teleology":[{"year":1994,"claim":"Established that Kir2.1 inward rectification is not purely intrinsic to the protein but requires defined intracellular conditions, settling how the channel achieves voltage-dependent gating.","evidence":"Whole-cell and single-channel recording in MEL cells and giant inside-out patches with Mg2+, ATP, and kinase manipulation","pmids":["8189383","7993632"],"confidence":"High","gaps":["Did not identify the polyamine blockers later shown to mediate rectification","Structural basis of the Mg2+/ATP requirement not resolved"]},{"year":1996,"claim":"Defined how permeant ions and intracellular blockers cooperate to produce rectification, and identified specific kinase phosphorylation sites controlling channel activity.","evidence":"Patch-clamp polyamine block kinetics across K+ concentrations; PKA/PKC pharmacology and S425N mutagenesis in COS-7/tsA cells","pmids":["8854340","8650176","8609894"],"confidence":"High","gaps":["Did not resolve the pore structure accommodating multiple blocker binding sites","Physiological receptor inputs driving phosphorylation in native tissue not fully mapped"]},{"year":1997,"claim":"Localized a specific pore residue (Arg148) acting as an external barrier governing cationic blocker and divalent access, refining the rectification mechanism at atomic resolution.","evidence":"R148H mutagenesis, single-channel recording, ion selectivity and block analysis in Xenopus oocytes","pmids":["9382895"],"confidence":"High","gaps":["Charge effect inferred functionally without structure at the time","Relationship to cytoplasmic blocker sites not integrated"]},{"year":1998,"claim":"Identified an additional regulatory layer through tyrosine-kinase suppression at Y242 and characterized the basal transcriptional control of KCNJ2.","evidence":"Y242F mutagenesis with growth-factor receptor coexpression; promoter deletion and transcription-factor cotransfection assays","pmids":["9852063","9712915"],"confidence":"High","gaps":["In vivo relevance of growth-factor suppression in heart/muscle unquantified","Tissue-selective repressor elements not molecularly identified"]},{"year":2000,"claim":"Demonstrated through genetic knockout that Kir2.1 is required for inward rectifier currents and K+-induced vasodilation in arterial smooth muscle, establishing a physiological role outside cardiac excitability.","evidence":"Kir2.1-/- mice, myocyte patch-clamp, pressurized cerebral artery dilation","pmids":["10904001"],"confidence":"High","gaps":["Endothelial versus smooth-muscle contribution not separated at this stage","Downstream coupling to dilatory effectors not defined"]},{"year":2001,"claim":"Identified KCNJ2 as the causative gene for Andersen's syndrome and showed mutations act through loss-of-function with dominant-negative suppression, defining the disease mechanism.","evidence":"Genetic mapping and two-electrode voltage-clamp of mutants in Xenopus oocytes; AKAP79 co-IP/pulldown linking PKA anchoring","pmids":["11371347","11287423"],"confidence":"High","gaps":["Did not distinguish trafficking versus assembly defects among mutations","Tissue-specific phenotype variability unexplained"]},{"year":2002,"claim":"Connected reduced Kir2.1 current to specific arrhythmogenic action-potential changes and broadened the picture with subtype heteromerization, subcellular distribution, and Ras-MAPK regulation.","evidence":"Voltage-clamp of 10 ATS mutants with computational myocyte modeling; Kir2.4 co-assembly pulldowns; cardiomyocyte immunocytochemistry; Ras-L61/MEK-inhibitor localization studies","pmids":["12163457","12148092","12381809","12181143","11809752","12045162"],"confidence":"High","gaps":["Heteromer stoichiometry in native tissue not quantified","Mechanistic link between MAPK and trafficking machinery incomplete"]},{"year":2003,"claim":"Resolved that distinct ATS mutations cause dysfunction by mechanistically separable routes — dominant-negative co-assembly, trafficking failure, or haploinsufficiency — and identified filamin-A as a trafficking-promoting partner.","evidence":"HEK293 patch-clamp with confocal/FRET trafficking analysis of multiple mutants; yeast two-hybrid, reciprocal pulldown, and co-IP for filamin-A","pmids":["14522976","12689820","12923176"],"confidence":"High","gaps":["Determinants selecting which mutation follows which route not predictive","Filamin-A interaction interface not mapped to atomic detail"]},{"year":2005,"claim":"Provided structural grounding for rectification via the cytoplasmic G-loop and di-aspartate cluster, and established that gain-of-function mutations produce a clinically distinct short-QT/atrial-fibrillation phenotype.","evidence":"X-ray crystallography of cytoplasmic domains with mutagenesis; D172N and V93I gain-of-function patch-clamp with ventricular modeling; YxxΦ Golgi-export chimera analysis","pmids":["15723059","15761194","15922306","15827083"],"confidence":"High","gaps":["Full-length channel structure in membrane not solved","How export motif sets heteromer surface stoichiometry mechanistically unresolved"]},{"year":2006,"claim":"Pinpointed the G-loop residue V302 as critical for both K+ conduction and PIP2 gating, linking a trafficking-normal ATS mutation directly to a permeation defect.","evidence":"Systematic V302 substitution mutagenesis with patch-clamp, surface assays, and structure-guided interpretation","pmids":["17166852"],"confidence":"High","gaps":["Coupling between PIP2 binding and G-loop conduction not kinetically dissected","T192 PIP2-site contribution addressed separately and incompletely"]},{"year":2011,"claim":"Established kinase-controlled degradation by showing AMPK reduces Kir2.1 surface abundance through Nedd4-2, embedding the channel in metabolic-stress signaling.","evidence":"Xenopus oocyte coexpression, voltage-clamp, confocal surface imaging, Nedd4-2 S795A mutagenesis","pmids":["21501591"],"confidence":"Medium","gaps":["Direct Kir2.1 ubiquitination by Nedd4-2 not demonstrated here","Native-tissue relevance not tested"]},{"year":2013,"claim":"Mapped the degradation and surface-trafficking machinery (lysosome, ESCRT, ERAD, α-arrestins) and characterized additional gain-of-function mutations disrupting rectification through heteromerization.","evidence":"Yeast synthetic gene array screens with human-cell validation and surface-quantification fusions; E299V patch-clamp, co-IP, and modeling; zacopride PKA-dependent activation via S425","pmids":["24227888","29784874","23440193","23929001"],"confidence":"High","gaps":["Relative flux through ESCRT versus ERAD in native cardiomyocytes unknown","Mammalian orthologs of α-arrestin effects not fully validated"]},{"year":2014,"claim":"Connected charge-dependent loss of rectification to disease and showed SQT3 mutations gain function additionally by altering ubiquitylation, lipid-raft partitioning, and caveolin interactions.","evidence":"M301K/R/A mutagenesis with cardiomyocyte overexpression; ubiquitylation, raft fractionation, caveolin co-IP, and patch-clamp","pmids":["22155372","24794859"],"confidence":"High","gaps":["Whether stability and conduction changes are mechanistically coupled unresolved","Caveolin-1 versus caveolin-2 functional division not fully defined"]},{"year":2016,"claim":"Revealed a non-excitable, bioelectric role for Kir2.1 in craniofacial development and identified Cdo/p38MAPK as a trafficking-promoting axis in myogenesis.","evidence":"Xenopus optogenetics, voltage-dye imaging, ATS-mutation expression, Kcnj2 KO mouse analysis; Cdo co-IP, surface assays, MKK6(EE) rescue in primary myoblasts","pmids":["26864374","27380411"],"confidence":"High","gaps":["How membrane voltage is transduced to patterning-gene expression mechanistically unclear","Cdo interaction interface not mapped"]},{"year":2018,"claim":"Defined the cardiac Kir2.1-Nav1.5 macromolecular complex — co-trafficked from the trans-Golgi via AP1 and reciprocally regulated — establishing channel interdependence relevant to both ATS and Brugada syndrome.","evidence":"Co-IP, FRAP, biotinylation, AP1 silencing in hiPSC-CMs; SCN5A haploinsufficient mice and hiPSC-CMs with trafficking-defective Nav1.5 mutants; PLA and CaMKII/14-3-3 inhibitor analysis","pmids":["29514831","30232268","29184507"],"confidence":"High","gaps":["Stoichiometry of the channelosome unresolved","GRASP-dependent unconventional rescue route mechanistically incomplete"]},{"year":2018,"claim":"Demonstrated a conduction-independent oncogenic function of Kir2.1, scaffolding kinase signaling to drive EMT, invasion, and drug resistance in cancer.","evidence":"Co-IP of Stk38 and MRP1, knockdown/overexpression, ubiquitination assays, and invasion/drug-resistance assays in gastric and small-cell lung cancer","pmids":["29549164","25880778"],"confidence":"Medium","gaps":["Direct versus indirect nature of interactions not fully resolved","In vivo tumor relevance limited to single labs"]},{"year":2022,"claim":"Extended Kir2.1 into immunometabolism, showing its hyperpolarizing current controls macrophage polarization and nutrient transport, linking membrane bioelectrics to inflammatory and metabolic programs.","evidence":"Genetic and pharmacological inhibition, Ca2+ imaging, phospholipid and epigenetic analysis, in vivo sepsis/peritonitis models","pmids":["35729093","35694964"],"confidence":"Medium","gaps":["Direct molecular sensor coupling hyperpolarization to transporter retention not defined","Whether channel conduction or scaffolding dominates not separated"]},{"year":2024,"claim":"Identified Kir2.1 as a tractable node in neural injury, where its inhibition mitigates neurodegenerative hallmarks after mechanical brain injury.","evidence":"Genome-wide CRISPRi screen in iPSC cortical organoids with ultrasound injury and in vivo validation; prior microglial Kir2.1 work in neuropathic pain","pmids":["38579683","32220118"],"confidence":"Medium","gaps":["Mechanism linking Kir2.1 activity to tau phosphorylation and TDP-43 mislocalization unknown","Cell-type contribution (neuron vs glia) not separated"]},{"year":null,"claim":"How Kir2.1's conducting and non-conducting (scaffolding/bioelectric) functions are partitioned across tissues, and how membrane voltage is mechanistically transduced into developmental, immune, and signaling outputs, remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking ion conduction to scaffolding functions","Signal transduction from membrane potential to gene-expression programs undefined","Full-length membrane-embedded structure with regulatory partners not solved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,9,11,42,48]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[20,21,22]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[16,18,33]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,17,20]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[8,31]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[24,28]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[49,50]},{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[37]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[35,36]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[38,41]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[8,31,39]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,6,23]}],"complexes":["Kir2.1-Nav1.5 channelosome","Kir2.x heterotetramers (Kir2.4, Kir5.1)"],"partners":["FLNA","AKAP5","KCNJ16","KCNJ14","SCN5A","NEDD4L","STK38","CDON"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P63252","full_name":"Inward rectifier potassium channel 2","aliases":["Cardiac inward rectifier potassium channel","Inward rectifier K(+) channel Kir2.1","IRK-1","hIRK1","Potassium channel, inwardly rectifying subfamily J member 2"],"length_aa":427,"mass_kda":48.3,"function":"Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:36149965, PubMed:7590287, PubMed:9490857). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:7590287, PubMed:7696590). The inward rectification is mainly due to the blockage of outward current by internal magnesium (PubMed:9490857). Can be blocked by extracellular barium or cesium (PubMed:7590287, PubMed:7696590). Probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues (PubMed:7590287, PubMed:7696590, PubMed:7840300)","subcellular_location":"Cell membrane; Cell membrane, sarcolemma, T-tubule","url":"https://www.uniprot.org/uniprotkb/P63252/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNJ2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNJ2","total_profiled":1310},"omim":[{"mim_id":"617061","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44","url":"https://www.omim.org/entry/617061"},{"mim_id":"614834","title":"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 3; TTPP3","url":"https://www.omim.org/entry/614834"},{"mim_id":"613980","title":"ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9","url":"https://www.omim.org/entry/613980"},{"mim_id":"613677","title":"HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3","url":"https://www.omim.org/entry/613677"},{"mim_id":"613485","title":"LONG QT SYNDROME 13; LQT13","url":"https://www.omim.org/entry/613485"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"parathyroid gland","ntpm":33.9}],"url":"https://www.proteinatlas.org/search/KCNJ2"},"hgnc":{"alias_symbol":["Kir2.1","IRK1","LQT7"],"prev_symbol":[]},"alphafold":{"accession":"P63252","domains":[{"cath_id":"1.10.287.70","chopping":"80-184","consensus_level":"high","plddt":93.6626,"start":80,"end":184},{"cath_id":"2.60.40.1400","chopping":"188-358","consensus_level":"high","plddt":94.6866,"start":188,"end":358}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P63252","model_url":"https://alphafold.ebi.ac.uk/files/AF-P63252-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P63252-F1-predicted_aligned_error_v6.png","plddt_mean":81.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNJ2","jax_strain_url":"https://www.jax.org/strain/search?query=KCNJ2"},"sequence":{"accession":"P63252","fasta_url":"https://rest.uniprot.org/uniprotkb/P63252.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P63252/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P63252"}},"corpus_meta":[{"pmid":"17401374","id":"PMC_17401374","title":"The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2.","date":"2007","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17401374","citation_count":906,"is_preprint":false},{"pmid":"11371347","id":"PMC_11371347","title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.","date":"2001","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11371347","citation_count":726,"is_preprint":false},{"pmid":"15761194","id":"PMC_15761194","title":"A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15761194","citation_count":446,"is_preprint":false},{"pmid":"12163457","id":"PMC_12163457","title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12163457","citation_count":393,"is_preprint":false},{"pmid":"15922306","id":"PMC_15922306","title":"A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15922306","citation_count":297,"is_preprint":false},{"pmid":"10904001","id":"PMC_10904001","title":"Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation.","date":"2000","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/10904001","citation_count":284,"is_preprint":false},{"pmid":"15723059","id":"PMC_15723059","title":"Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.","date":"2005","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15723059","citation_count":240,"is_preprint":false},{"pmid":"31358994","id":"PMC_31358994","title":"Functional dissection of the Sox9-Kcnj2 locus identifies nonessential and instructive roles of TAD architecture.","date":"2019","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31358994","citation_count":231,"is_preprint":false},{"pmid":"15911703","id":"PMC_15911703","title":"Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype.","date":"2005","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/15911703","citation_count":208,"is_preprint":false},{"pmid":"12148092","id":"PMC_12148092","title":"KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes.","date":"2002","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12148092","citation_count":176,"is_preprint":false},{"pmid":"15465867","id":"PMC_15465867","title":"Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels.","date":"2004","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15465867","citation_count":155,"is_preprint":false},{"pmid":"7993632","id":"PMC_7993632","title":"Kir2.1 inward rectifier K+ channels are regulated independently by protein kinases and ATP hydrolysis.","date":"1994","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/7993632","citation_count":135,"is_preprint":false},{"pmid":"27696527","id":"PMC_27696527","title":"Differential Kv1.3, KCa3.1, and Kir2.1 expression in \"classically\" and \"alternatively\" activated microglia.","date":"2016","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/27696527","citation_count":134,"is_preprint":false},{"pmid":"14522976","id":"PMC_14522976","title":"Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14522976","citation_count":129,"is_preprint":false},{"pmid":"26840527","id":"PMC_26840527","title":"Inward rectifier potassium (Kir2.1) channels as end-stage boosters of endothelium-dependent vasodilators.","date":"2016","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26840527","citation_count":111,"is_preprint":false},{"pmid":"23440193","id":"PMC_23440193","title":"KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23440193","citation_count":109,"is_preprint":false},{"pmid":"26864374","id":"PMC_26864374","title":"Bioelectric signalling via potassium channels: a mechanism for craniofacial dysmorphogenesis in KCNJ2-associated Andersen-Tawil Syndrome.","date":"2016","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26864374","citation_count":106,"is_preprint":false},{"pmid":"29514831","id":"PMC_29514831","title":"Cardiac Kir2.1 and NaV1.5 Channels Traffic Together to the Sarcolemma to Control Excitability.","date":"2018","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/29514831","citation_count":92,"is_preprint":false},{"pmid":"8189383","id":"PMC_8189383","title":"The intrinsic gating of inward rectifier K+ channels expressed from the murine IRK1 gene depends on voltage, K+ and Mg2+.","date":"1994","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8189383","citation_count":89,"is_preprint":false},{"pmid":"25880778","id":"PMC_25880778","title":"Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.","date":"2015","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25880778","citation_count":84,"is_preprint":false},{"pmid":"12181143","id":"PMC_12181143","title":"Differential distribution of Kir2.1 and Kir2.3 subunits in canine atrium and ventricle.","date":"2002","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12181143","citation_count":82,"is_preprint":false},{"pmid":"22589293","id":"PMC_22589293","title":"Phenotype variability in patients carrying KCNJ2 mutations.","date":"2012","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22589293","citation_count":81,"is_preprint":false},{"pmid":"8854340","id":"PMC_8854340","title":"[K+] dependence of polyamine-induced rectification in inward rectifier potassium channels (IRK1, Kir2.1).","date":"1996","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8854340","citation_count":79,"is_preprint":false},{"pmid":"12045162","id":"PMC_12045162","title":"Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia.","date":"2002","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/12045162","citation_count":76,"is_preprint":false},{"pmid":"9852063","id":"PMC_9852063","title":"Acute suppression of inwardly rectifying Kir2.1 channels by direct tyrosine kinase phosphorylation.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9852063","citation_count":75,"is_preprint":false},{"pmid":"8650176","id":"PMC_8650176","title":"Receptor stimulation causes slow inhibition of IRK1 inwardly rectifying K+ channels by direct protein kinase A-mediated phosphorylation.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8650176","citation_count":74,"is_preprint":false},{"pmid":"17551083","id":"PMC_17551083","title":"Pierre Robin sequence may be caused by dysregulation of SOX9 and KCNJ2.","date":"2007","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17551083","citation_count":72,"is_preprint":false},{"pmid":"12923176","id":"PMC_12923176","title":"Direct interaction between the actin-binding protein filamin-A and the inwardly rectifying potassium channel, Kir2.1.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12923176","citation_count":72,"is_preprint":false},{"pmid":"23867365","id":"PMC_23867365","title":"Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.","date":"2013","source":"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23867365","citation_count":67,"is_preprint":false},{"pmid":"15827083","id":"PMC_15827083","title":"Selective Golgi export of Kir2.1 controls the stoichiometry of functional Kir2.x channel heteromers.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15827083","citation_count":67,"is_preprint":false},{"pmid":"24794859","id":"PMC_24794859","title":"Genetically induced dysfunctions of Kir2.1 channels: implications for short QT3 syndrome and autism-epilepsy phenotype.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24794859","citation_count":66,"is_preprint":false},{"pmid":"22155372","id":"PMC_22155372","title":"A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.","date":"2011","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/22155372","citation_count":65,"is_preprint":false},{"pmid":"17221872","id":"PMC_17221872","title":"Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17221872","citation_count":62,"is_preprint":false},{"pmid":"16500306","id":"PMC_16500306","title":"Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).","date":"2006","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/16500306","citation_count":60,"is_preprint":false},{"pmid":"29549164","id":"PMC_29549164","title":"Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2-MEK1/2-ERK1/2 Signaling.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29549164","citation_count":56,"is_preprint":false},{"pmid":"29571612","id":"PMC_29571612","title":"Kir2.1 is important for efficient BMP signaling in mammalian face development.","date":"2018","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29571612","citation_count":56,"is_preprint":false},{"pmid":"11287423","id":"PMC_11287423","title":"Targeting of an A kinase-anchoring protein, AKAP79, to an inwardly rectifying potassium channel, Kir2.1.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11287423","citation_count":56,"is_preprint":false},{"pmid":"14602583","id":"PMC_14602583","title":"Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels.","date":"2003","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14602583","citation_count":52,"is_preprint":false},{"pmid":"12689820","id":"PMC_12689820","title":"Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome.","date":"2003","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/12689820","citation_count":51,"is_preprint":false},{"pmid":"11240146","id":"PMC_11240146","title":"Genetic and functional linkage of Kir5.1 and Kir2.1 channel subunits.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11240146","citation_count":51,"is_preprint":false},{"pmid":"19843922","id":"PMC_19843922","title":"Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.","date":"2009","source":"Circulation. Arrhythmia and electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/19843922","citation_count":49,"is_preprint":false},{"pmid":"11827999","id":"PMC_11827999","title":"Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility.","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11827999","citation_count":47,"is_preprint":false},{"pmid":"35729093","id":"PMC_35729093","title":"Kir2.1-mediated membrane potential promotes nutrient acquisition and inflammation through regulation of nutrient transporters.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35729093","citation_count":45,"is_preprint":false},{"pmid":"12381809","id":"PMC_12381809","title":"Kir2.4 and Kir2.1 K(+) channel subunits co-assemble: a potential new contributor to inward rectifier current heterogeneity.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12381809","citation_count":45,"is_preprint":false},{"pmid":"17166852","id":"PMC_17166852","title":"An andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17166852","citation_count":45,"is_preprint":false},{"pmid":"11566119","id":"PMC_11566119","title":"Channelopathies: Kir2.1 mutations jeopardize many cell functions.","date":"2001","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11566119","citation_count":43,"is_preprint":false},{"pmid":"30232268","id":"PMC_30232268","title":"Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/30232268","citation_count":43,"is_preprint":false},{"pmid":"29191750","id":"PMC_29191750","title":"Sucrose withdrawal induces depression and anxiety-like behavior by Kir2.1 upregulation in the nucleus accumbens.","date":"2017","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29191750","citation_count":43,"is_preprint":false},{"pmid":"16541386","id":"PMC_16541386","title":"Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome.","date":"2006","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16541386","citation_count":42,"is_preprint":false},{"pmid":"16330144","id":"PMC_16330144","title":"Differential regulation of Kir4.1 and Kir2.1 expression in the ischemic rat retina.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16330144","citation_count":42,"is_preprint":false},{"pmid":"18182162","id":"PMC_18182162","title":"Lysosome mediated Kir2.1 breakdown directly influences inward rectifier current density.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18182162","citation_count":42,"is_preprint":false},{"pmid":"26224687","id":"PMC_26224687","title":"Two inwardly rectifying potassium channels, Irk1 and Irk2, play redundant roles in Drosophila renal tubule function.","date":"2015","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26224687","citation_count":41,"is_preprint":false},{"pmid":"17341397","id":"PMC_17341397","title":"KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.","date":"2006","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/17341397","citation_count":41,"is_preprint":false},{"pmid":"15851159","id":"PMC_15851159","title":"Polymorphic ventricular tachycardia and KCNJ2 mutations.","date":"2004","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/15851159","citation_count":37,"is_preprint":false},{"pmid":"22308236","id":"PMC_22308236","title":"Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling.","date":"2012","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/22308236","citation_count":37,"is_preprint":false},{"pmid":"21501591","id":"PMC_21501591","title":"Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21501591","citation_count":36,"is_preprint":false},{"pmid":"29184507","id":"PMC_29184507","title":"Kir2.1-Nav1.5 Channel Complexes Are Differently Regulated than Kir2.1 and Nav1.5 Channels Alone.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29184507","citation_count":36,"is_preprint":false},{"pmid":"18178799","id":"PMC_18178799","title":"Inward rectifier K(+) currents and Kir2.1 expression in renal afferent and efferent arterioles.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/18178799","citation_count":35,"is_preprint":false},{"pmid":"38579683","id":"PMC_38579683","title":"KCNJ2 inhibition mitigates mechanical injury in a human brain organoid model of traumatic brain injury.","date":"2024","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/38579683","citation_count":34,"is_preprint":false},{"pmid":"35223865","id":"PMC_35223865","title":"Inwardly Rectifying Potassium Channel Kir2.1 and its \"Kir-ious\" Regulation by Protein Trafficking and Roles in Development and Disease.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35223865","citation_count":33,"is_preprint":false},{"pmid":"16571646","id":"PMC_16571646","title":"Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.","date":"2006","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16571646","citation_count":31,"is_preprint":false},{"pmid":"10516659","id":"PMC_10516659","title":"Direct block of native and cloned (Kir2.1) inward rectifier K+ channels by chloroethylclonidine.","date":"1999","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10516659","citation_count":31,"is_preprint":false},{"pmid":"9382895","id":"PMC_9382895","title":"A conserved arginine residue in the pore region of an inward rectifier K channel (IRK1) as an external barrier for cationic blockers.","date":"1997","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9382895","citation_count":31,"is_preprint":false},{"pmid":"17289820","id":"PMC_17289820","title":"Cloning and expression of cardiac Kir2.1 and Kir2.2 channels in thermally acclimated rainbow trout.","date":"2007","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17289820","citation_count":30,"is_preprint":false},{"pmid":"32954646","id":"PMC_32954646","title":"Long noncoding RNA TCONS-00106987 promotes atrial electrical remodelling during atrial fibrillation by sponging miR-26 to regulate KCNJ2.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32954646","citation_count":30,"is_preprint":false},{"pmid":"24227888","id":"PMC_24227888","title":"ESCRT regulates surface expression of the Kir2.1 potassium channel.","date":"2013","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/24227888","citation_count":29,"is_preprint":false},{"pmid":"17534603","id":"PMC_17534603","title":"Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.","date":"2007","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17534603","citation_count":29,"is_preprint":false},{"pmid":"21148745","id":"PMC_21148745","title":"Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.","date":"2010","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21148745","citation_count":29,"is_preprint":false},{"pmid":"32986966","id":"PMC_32986966","title":"Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.","date":"2020","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32986966","citation_count":28,"is_preprint":false},{"pmid":"24561538","id":"PMC_24561538","title":"KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia.","date":"2014","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/24561538","citation_count":28,"is_preprint":false},{"pmid":"11809752","id":"PMC_11809752","title":"Modulation of the inward rectifier potassium channel IRK1 by the Ras signaling pathway.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11809752","citation_count":28,"is_preprint":false},{"pmid":"19366693","id":"PMC_19366693","title":"Specific and slow inhibition of the kir2.1 K+ channel by gambogic acid.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19366693","citation_count":27,"is_preprint":false},{"pmid":"17640933","id":"PMC_17640933","title":"Low-affinity spermine block mediating outward currents through Kir2.1 and Kir2.2 inward rectifier potassium channels.","date":"2007","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17640933","citation_count":27,"is_preprint":false},{"pmid":"10103089","id":"PMC_10103089","title":"Expression of Ras-GRF in the SK-N-BE neuroblastoma accelerates retinoic-acid-induced neuronal differentiation and increases the functional expression of the IRK1 potassium channel.","date":"1999","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10103089","citation_count":26,"is_preprint":false},{"pmid":"23188060","id":"PMC_23188060","title":"Up-regulation of the inwardly rectifying K⁺ channel Kir2.1 (KCNJ2) by protein kinase B (PKB/Akt) and PIKfyve.","date":"2012","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/23188060","citation_count":26,"is_preprint":false},{"pmid":"11566776","id":"PMC_11566776","title":"Unitary conductance variation in Kir2.1 and in cardiac inward rectifier potassium channels.","date":"2001","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11566776","citation_count":26,"is_preprint":false},{"pmid":"35694964","id":"PMC_35694964","title":"Kir2.1 channel regulates macrophage polarization via the Ca2+/CaMK II/ERK/NF-κB signaling pathway.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/35694964","citation_count":25,"is_preprint":false},{"pmid":"9712915","id":"PMC_9712915","title":"Multiple promoter elements interact to control the transcription of the potassium channel gene, KCNJ2.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9712915","citation_count":25,"is_preprint":false},{"pmid":"28609477","id":"PMC_28609477","title":"Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.","date":"2017","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/28609477","citation_count":25,"is_preprint":false},{"pmid":"9535729","id":"PMC_9535729","title":"Long-term exposure to retinoic acid induces the expression of IRK1 channels in HERG channel-endowed neuroblastoma cells.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9535729","citation_count":25,"is_preprint":false},{"pmid":"17675572","id":"PMC_17675572","title":"Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicity.","date":"2007","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17675572","citation_count":25,"is_preprint":false},{"pmid":"8609894","id":"PMC_8609894","title":"Modulation of the inwardly rectifying potassium channel IRK1 by the m1 muscarinic receptor.","date":"1996","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8609894","citation_count":24,"is_preprint":false},{"pmid":"23644778","id":"PMC_23644778","title":"Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.","date":"2013","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23644778","citation_count":22,"is_preprint":false},{"pmid":"29615871","id":"PMC_29615871","title":"A Novel KCNJ2 Mutation Identified in an Autistic Proband Affects the Single Channel Properties of Kir2.1.","date":"2018","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29615871","citation_count":21,"is_preprint":false},{"pmid":"32220118","id":"PMC_32220118","title":"The inhibition of Kir2.1 potassium channels depolarizes spinal microglial cells, reduces their proliferation, and attenuates neuropathic pain.","date":"2020","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/32220118","citation_count":21,"is_preprint":false},{"pmid":"23929001","id":"PMC_23929001","title":"Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes.","date":"2013","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23929001","citation_count":21,"is_preprint":false},{"pmid":"23807091","id":"PMC_23807091","title":"Cholesterol sensitivity of KIR2.1 depends on functional inter-links between the N and C termini.","date":"2013","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23807091","citation_count":21,"is_preprint":false},{"pmid":"37326915","id":"PMC_37326915","title":"Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling.","date":"2023","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/37326915","citation_count":20,"is_preprint":false},{"pmid":"17399639","id":"PMC_17399639","title":"Kir2.3 isoform confers pH sensitivity to heteromeric Kir2.1/Kir2.3 channels in HEK293 cells.","date":"2006","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/17399639","citation_count":19,"is_preprint":false},{"pmid":"27235552","id":"PMC_27235552","title":"Hypoxic stress up-regulates Kir2.1 expression and facilitates cell proliferation in brain capillary endothelial cells.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27235552","citation_count":19,"is_preprint":false},{"pmid":"33669857","id":"PMC_33669857","title":"Potassium Channels Kv1.3 and Kir2.1 But Not Kv1.5 Contribute to BV2 Cell Line and Primary Microglial Migration.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33669857","citation_count":19,"is_preprint":false},{"pmid":"29784874","id":"PMC_29784874","title":"Select α-arrestins control cell-surface abundance of the mammalian Kir2.1 potassium channel in a yeast model.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29784874","citation_count":18,"is_preprint":false},{"pmid":"24556932","id":"PMC_24556932","title":"Up-regulation of Kir2.1 (KCNJ2) by the serum & glucocorticoid inducible SGK3.","date":"2014","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24556932","citation_count":17,"is_preprint":false},{"pmid":"18319624","id":"PMC_18319624","title":"Expression of Kir2.1 channels in astrocytes under pathophysiological conditions.","date":"2008","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/18319624","citation_count":17,"is_preprint":false},{"pmid":"27380411","id":"PMC_27380411","title":"Cdo Regulates Surface Expression of Kir2.1 K+ Channel in Myoblast Differentiation.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27380411","citation_count":17,"is_preprint":false},{"pmid":"32554946","id":"PMC_32554946","title":"Magnesium Deficiency Causes Transcriptional Downregulation of Kir2.1 and Kv4.2 Channels in Cardiomyocytes Resulting in QT Interval Prolongation.","date":"2020","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/32554946","citation_count":17,"is_preprint":false},{"pmid":"12882801","id":"PMC_12882801","title":"Expression of the inwardly rectifying K+ channel Kir2.1 in native bovine corneal endothelial cells.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12882801","citation_count":17,"is_preprint":false},{"pmid":"25727015","id":"PMC_25727015","title":"Inwardly rectifying Kir2.1 currents in human β-cells control electrical activity: characterisation and mathematical modelling.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25727015","citation_count":16,"is_preprint":false},{"pmid":"22186697","id":"PMC_22186697","title":"Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.","date":"2011","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22186697","citation_count":16,"is_preprint":false},{"pmid":"29021306","id":"PMC_29021306","title":"Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation.","date":"2017","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29021306","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55131,"output_tokens":12634,"usd":0.177452,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":24173,"output_tokens":6241,"usd":0.138445,"stage2_stop_reason":"end_turn"},"total_usd":0.315897,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Loss-of-function mutations in KCNJ2 (Kir2.1) cause Andersen's syndrome. Expression of D71V and other mutations in Xenopus oocytes revealed loss of function and a dominant-negative effect on Kir2.1 current by voltage-clamp, establishing KCNJ2 as the causative gene.\",\n      \"method\": \"Xenopus oocyte expression system, two-electrode voltage-clamp, genetic mapping\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct functional assay (voltage-clamp) with multiple mutations, replicated across subsequent studies\",\n      \"pmids\": [\"11371347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Ten KCNJ2 mutations associated with Andersen syndrome all resulted in loss of function and dominant-negative suppression of Kir2.1 channel function when assessed by two-microelectrode voltage-clamp in Xenopus oocytes. Computer simulation showed reduced Kir2.1 prolongs terminal action potential phase and, at low extracellular K+, induces Na+/Ca2+ exchanger-dependent delayed afterdepolarizations.\",\n      \"method\": \"Two-microelectrode voltage-clamp (Xenopus oocytes), ventricular myocyte computational modeling\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro functional assay across 10 mutations with mechanistic modeling, replicated dominant-negative mechanism\",\n      \"pmids\": [\"12163457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The R67W KCNJ2 mutation demonstrates loss of function and a dominant-negative effect on Kir2.1 current, establishing that Kir2.1 plays roles in both cardiac/skeletal muscle excitability and developmental signaling.\",\n      \"method\": \"Biophysical characterization by voltage-clamp in Xenopus oocytes\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional voltage-clamp assay, single lab, consistent with replicated dominant-negative mechanism\",\n      \"pmids\": [\"12148092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Different Andersen-Tawil syndrome KCNJ2 mutations cause channel dysfunction via distinct mechanisms: (1) some mutants co-assemble with wild-type at the membrane and exert dominant-negative effects; (2) V302M mutant loses co-assembly ability with wild-type and fails to traffic to the cell surface; (3) deletion mutants (Δ95-98, Δ314-315) fail to traffic to the membrane but retain co-assembly with wild-type, causing haplo-insufficiency.\",\n      \"method\": \"Heterologous expression in HEK293 cells, whole-cell patch-clamp, confocal fluorescence microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (electrophysiology + imaging), multiple mutations tested, mechanistically distinguishes trafficking vs. dominant-negative mechanisms\",\n      \"pmids\": [\"14522976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Filamin-A directly interacts with Kir2.1 via the Kir2.1 carboxyl terminus. This interaction increases the number of functional Kir2.1 channels at the plasma membrane without altering single-channel properties.\",\n      \"method\": \"Yeast two-hybrid screen, GST pulldown overlay assay, co-immunoprecipitation from arterial smooth muscle lysates, immunocytochemistry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal pulldown/co-IP, yeast two-hybrid, and colocalization with functional readout, multiple orthogonal methods in one study\",\n      \"pmids\": [\"12923176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structures of the cytoplasmic domains of Kir2.1 and Kir3.1 show a G-loop that forms a diffusion barrier between cytoplasmic and transmembrane pores. G-loop mutations disrupted gating or inward rectification. A di-aspartate cluster at the distal cytoplasmic pore of Kir2.1 modulates inward rectification.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, electrophysiology\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with mutagenesis and functional validation in a single study\",\n      \"pmids\": [\"15723059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The KCNJ2 D172N mutation causes a gain-of-function in Kir2.1 (SQT3): larger outward IK1 at potentials between -75 mV and -45 mV with a shifted peak current, due to altered inward rectification. This gain-of-function accelerates final repolarization, shortens action potential duration, and predicts steeper restitution favoring re-entrant arrhythmias.\",\n      \"method\": \"Whole-cell patch-clamp (heterologous expression), computational modeling of human ventricular myocyte\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro electrophysiology plus computational modeling, mechanism confirmed by subsequent replication\",\n      \"pmids\": [\"15761194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A Kir2.1 gain-of-function mutation (V93I) is associated with familial atrial fibrillation, demonstrating that increased Kir2.1 channel activity (opposed to ATS loss-of-function) can promote AF.\",\n      \"method\": \"Genetic screening, functional analysis by patch-clamp in heterologous expression system\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, single functional assay method; gain-of-function direction consistent with mechanism\",\n      \"pmids\": [\"15922306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Kir2.1 preferentially exports from the Golgi to the plasma membrane via a tyrosine-dependent YXXPhi motif in its C-terminus (20-amino acid stretch). This dominant Golgi export signal controls the stoichiometry of Kir2.x heteromers at the cell surface.\",\n      \"method\": \"Chimeric channel construction, functional expression in oocytes and mammalian cells, subcellular trafficking analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chimera/mutagenesis approach with functional readout and trafficking analysis, identifies specific motif mechanism\",\n      \"pmids\": [\"15827083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Kir2.1 gene expression in arterial smooth muscle is required for inward rectifier K+ currents and K+-induced vasodilation in cerebral arteries. Kir2.1 knockout mice lack these Kir currents and K+-induced dilatory response.\",\n      \"method\": \"Targeted gene disruption (Kir2.1-/- mice), patch-clamp of isolated cerebral artery myocytes, pressurized cerebral artery dilation assay\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with specific physiological phenotype, direct functional assay confirming absence of Kir current\",\n      \"pmids\": [\"10904001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Kir2.1 (IRK1) channel activity requires both PKA-mediated phosphorylation and ATP hydrolysis (via an ATPase-like mechanism). PKA increases current amplitude only when channels are also stimulated by Mg-ATP/Mg2+, while PKC activation down-regulates Kir2.1 currents, showing opposing regulation by these kinases.\",\n      \"method\": \"Giant inside-out patches from Xenopus oocytes, pharmacological manipulation of PKA, PKC, ATP analogs\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro biochemical reconstitution approach with multiple pharmacological probes, mechanistically defines dual requirement\",\n      \"pmids\": [\"7993632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Kir2.1 (IRK1) intrinsic gating depends on voltage, external K+ concentration, and intracellular Mg2+. Removal of intracellular Mg2+ permits brief outward currents at depolarization, demonstrating that Mg2+ is required for voltage-dependent gating/rectification.\",\n      \"method\": \"Stable expression in MEL cells, whole-cell and single-channel recording, Mg2+ manipulation\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiological characterization with defined ionic conditions, foundational mechanism paper\",\n      \"pmids\": [\"8189383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"PKA directly phosphorylates Kir2.1 (IRK1) at a C-terminal site (S425), mediating inhibition following serotonin 5-HT1A receptor activation via cAMP elevation. Mutant IRK1(S425N) lacking this PKA phosphorylation site is not inhibited by PKA.\",\n      \"method\": \"Whole-cell patch-clamp in COS-7 cells, pharmacological cAMP elevation, site-directed mutagenesis (S425N), receptor coexpression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis identifies specific phosphorylation site, receptor coexpression links signaling pathway to channel inhibition\",\n      \"pmids\": [\"8650176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"m1 muscarinic receptor stimulation inhibits Kir2.1 (IRK1) current via PKC activation. m2 receptor stimulation does not affect Kir2.1. PKC activator phorbol ester mimics m1 inhibition, and PKC inhibitors (staurosporine, calphostin C) prevent it. cAMP and intracellular Ca2+ are not involved.\",\n      \"method\": \"Whole-cell patch-clamp in tsA cells, receptor coexpression, pharmacological PKC manipulation\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct pharmacological dissection of signaling pathway with receptor selectivity controls, clear mechanistic conclusion\",\n      \"pmids\": [\"8609894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Tyrosine kinase phosphorylation directly suppresses Kir2.1 channel activity. The Y242 residue in the C-terminal domain is a direct TK substrate; Y242F mutant channels are insensitive to TK-mediated suppression. NGF, EGF, and insulin each suppress Kir2.1 activity via this mechanism.\",\n      \"method\": \"Patch-clamp in tsA-201 cells and Xenopus oocytes, site-directed mutagenesis (Y242F), receptor coexpression, pharmacological TK/PTP manipulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis identifies specific phosphorylation residue, multiple growth factor receptors tested, direct substrate demonstration\",\n      \"pmids\": [\"9852063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"AKAP79 directly associates with the Kir2.1 channel via both N- and C-terminal intracellular domains (demonstrated by GST pulldown and co-immunoprecipitation), and enhances Kir2.1 response to elevated intracellular cAMP, suggesting AKAP79 anchors PKA near Kir2.1 phosphorylation sites.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown from cell lysates, whole-cell patch-clamp with cAMP stimulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal pulldown and co-IP with functional electrophysiological validation, two orthogonal methods\",\n      \"pmids\": [\"11287423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Kir5.1 (KCNJ16) co-localizes with Kir2.1 in brain and kidney and forms electrically silent heteromeric channels with Kir2.1 when coexpressed in Xenopus oocytes, thereby negatively regulating Kir2.1 channel activity.\",\n      \"method\": \"Xenopus oocyte expression, two-electrode voltage-clamp, in situ hybridization, chromosomal mapping\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional co-expression assay demonstrating heteromerization, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"11240146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kir2.1 exhibits transverse tubular localization in ventricular cardiomyocytes (89% of cells) but less so in atrial cells (26%). Kir2.3 is strongly expressed at intercalated disks. These differential subcellular distributions contribute to the >10-fold larger IK1 in ventricle vs. atrium.\",\n      \"method\": \"Western blot, immunocytochemistry, patch-clamp electrophysiology in isolated canine cardiomyocytes\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by immunocytochemistry with functional correlation, two orthogonal methods\",\n      \"pmids\": [\"12181143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kir2.4 co-assembles with Kir2.1 to form functional heterotetrameric channels with properties distinct from either homomeric channel (greater Ba2+ sensitivity). Physical co-assembly confirmed by His-tag pulldown.\",\n      \"method\": \"Co-expression in Xenopus oocytes and COS-7 cells, dominant-negative suppression, His-tag pulldown/Western blot, tandem subunit expression\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-assembly confirmed by pulldown plus functional characterization via multiple methods\",\n      \"pmids\": [\"12381809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The G215D Kir2.1 mutant (Andersen syndrome) traffics normally to the plasma membrane, co-assembles with wild-type Kir2.1 into hetero-multimers (demonstrated by FRET), and exerts dominant-negative suppression of both inward and outward currents without trafficking defect.\",\n      \"method\": \"Whole-cell patch-clamp in COS7 cells, confocal microscopy with YFP/CFP-tagged channels, FRET analysis\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET demonstrates physical interaction, electrophysiology confirms functional dominant-negative effect, two orthogonal methods single lab\",\n      \"pmids\": [\"12689820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cholesterol increase suppresses Kir2.1 whole-cell current in null cell lines by promoting transition of channels between active and silent states, without altering total protein levels, surface expression, unitary conductance, or open probability significantly. Kir2.x channels partition almost exclusively into cholesterol-rich lipid rafts (Triton-insoluble fractions).\",\n      \"method\": \"Whole-cell patch-clamp, cholesterol manipulation, single-channel recording, Western blot, cell surface biotinylation, lipid raft fractionation\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods (electrophysiology, surface expression, raft fractionation), mechanistic conclusions about active/silent state transition\",\n      \"pmids\": [\"15465867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The KCNJ2 T192A mutation, located in the PIP2-binding site and Kir2.1 multimerization region, produces a non-functional channel and weak dominant-negative effect, implicating T192 as important for both PIP2 interaction and channel assembly.\",\n      \"method\": \"Xenopus oocyte expression system, voltage-clamp\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct functional assay establishing role of specific residue in PIP2 binding/multimerization, single lab single method\",\n      \"pmids\": [\"12045162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The V302M mutation in the Kir2.1 G-loop specifically abolishes K+ conduction without altering subunit assembly or surface expression. The V302 side chain is critical for G-loop potassium conduction and PIP2 gating. Amino acid substitution analysis shows channel activity and PIP2 sensitivity are highly sensitive to the size, shape, and hydrophobicity at position 302.\",\n      \"method\": \"Site-directed mutagenesis, heterologous expression, patch-clamp, cell surface expression assay, crystal structure interpretation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with crystal structure-guided analysis and functional validation, mechanistically defines G-loop gating role\",\n      \"pmids\": [\"17166852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"miR-1 post-transcriptionally represses KCNJ2 (Kir2.1) and GJA1 (connexin 43), causing membrane depolarization and slowed conduction. miR-1 overexpression in infarcted rat hearts exacerbates arrhythmogenesis, while antisense inhibitor of miR-1 relieves arrhythmogenesis.\",\n      \"method\": \"miRNA overexpression and antisense inhibition in rat hearts, electrophysiology, molecular target validation\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo gain- and loss-of-function with defined electrophysiological phenotype, widely replicated post-transcriptional regulation mechanism\",\n      \"pmids\": [\"17401374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Kir2.1 is degraded via the lysosomal pathway. Lysosomal inhibitors (NH4Cl, chloroquine, leupeptin) increase steady-state Kir2.1 protein levels and plasma membrane-originating inward rectifier current densities without altering current-voltage characteristics, establishing lysosomes as a major Kir2.1 degradation route.\",\n      \"method\": \"Lysosomal inhibitor treatment, Western blot, patch-clamp electrophysiology, confocal microscopy\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — three different lysosomal inhibitors with consistent protein and functional results, two orthogonal methods\",\n      \"pmids\": [\"18182162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"KCNJ2 V227F mutation causes a latent loss-of-function phenotype dependent on PKA-mediated phosphorylation at S425. Under basal conditions, V227F coexpressed with wild-type produces normal IK1, but PKA stimulation markedly reduces outward IK1. The S425N phosphorylation-null mutation eliminates PKA-induced reduction.\",\n      \"method\": \"Heterologous expression in COS-1 cells, whole-cell voltage-clamp, PKA-stimulating cocktail (forskolin/IBMX), site-directed mutagenesis (S425N)\",\n      \"journal\": \"Circulation. Arrhythmia and electrophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis identifies specific phosphorylation site as required for phenotype, direct functional assay\",\n      \"pmids\": [\"19843922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"AMPK inhibits Kir2.1 by reducing channel protein abundance at the plasma membrane. This effect is partially mediated through AMPK phosphorylation of the ubiquitin ligase Nedd4-2; Nedd4-2(S795A) lacking the AMPK phosphorylation site is not augmented by AMPK, though wild-type Nedd4-2 alone also downregulates Kir2.1 currents.\",\n      \"method\": \"Xenopus oocyte co-expression, two-electrode voltage-clamp, confocal imaging of membrane protein abundance, mutagenesis of AMPK phosphorylation site on Nedd4-2\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay with mutagenesis defining Nedd4-2 phosphorylation site, two methods in single lab\",\n      \"pmids\": [\"21501591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"E299V KCNJ2 mutation causes gain-of-function with loss of inward rectification, generating a large abnormal outward IK1. Co-immunoprecipitation and kinetic analysis showed E299V and wild-type isoforms heteromerize, impairing function. Homomeric E299V results in gain-of-function.\",\n      \"method\": \"Whole-cell patch-clamp, co-immunoprecipitation, kinetic analysis, computational modeling\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — electrophysiology plus co-IP to demonstrate heteromerization, computational modeling validates phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"23440193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ESCRT (endosomal sorting complex required for transport) and ERAD (ER-associated degradation) both mediate Kir2.1 degradation in human cells, with ESCRT playing a more prominent role in controlling Kir2.1 surface expression.\",\n      \"method\": \"Yeast genetic screen (synthetic gene array), heterologous expression in human cells, loss-of-function of ESCRT/ERAD pathway components\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide screen plus validation in human cells, two degradation systems identified with orthogonal approaches\",\n      \"pmids\": [\"24227888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A Kir2.1 gain-of-function mutation (M301K) causes loss of inward rectification in a charge-dependent manner. Homozygous M301K is non-functional, but heterozygous coexpression with wild-type yields larger outward currents above -30 mV. Neutral substitutions (M301A) show normal rectification, establishing that the positive charge at M301 specifically impairs rectification.\",\n      \"method\": \"Heterologous expression in mammalian cells, whole-cell patch-clamp, site-directed mutagenesis (M301K/R/A), neonatal rat ventricular myocyte overexpression\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with charge manipulation identifies specific mechanism, functional validation in cardiomyocytes\",\n      \"pmids\": [\"22155372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"An SQT3-associated Kir2.1 mutation enhances channel surface expression and stability by reducing ubiquitylation and proteasomal degradation, alters protein partitioning in lipid rafts (shifting to cholesterol-poor domains), and reduces interaction with caveolin-2. Wild-type Kir2.1 binds both caveolin-1 and caveolin-2 and is degraded via the ubiquitin-proteasome pathway.\",\n      \"method\": \"Surface expression assay, ubiquitylation assay, lipid raft fractionation, co-immunoprecipitation, patch-clamp\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ubiquitylation, raft fractionation, co-IP, electrophysiology) in a single study identifying novel regulatory mechanisms\",\n      \"pmids\": [\"24794859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Kir2.1 and Nav1.5 pre-assemble early in the forward trafficking pathway (at the trans-Golgi, via AP1 adaptor complex) and traffic together to common membrane microdomains. Trafficking-deficient Kir2.1 mutants reduce Nav1.5 surface expression; FRAP shows coexpression increases cytoplasmic mobility of both channels. AP1 co-localizes with and co-immunoprecipitates with both channels; Nav1.5 interacts with AP1 through Y1810.\",\n      \"method\": \"Patch-clamp, cell surface biotinylation, glycosylation analysis, FRAP, viral gene transfer in cardiomyocytes, co-immunoprecipitation, site-directed mutagenesis (Nav1.5Y1810), immunostaining, AP1 subunit silencing in hiPSC-CMs\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-IP, FRAP, biotinylation, mutagenesis, gene silencing) in heterologous and primary cell systems\",\n      \"pmids\": [\"29514831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In Kir2.1-Nav1.5 complexes, CaMKII inhibition decreases both INa and IK1 only when channels are coexpressed (not Kir2.1 alone), indicating the complex is a CaMKII substrate. 14-3-3 protein inhibition reduces currents from complexes but not individual channels. Dynamin-dependent endocytosis reduces Kir2.1 internalization but not Nav1.5 or the Kir2.1-Nav1.5 complex. The Kir2.1-Nav1.5 complex is degraded via Nedd4-2/proteasome pathway (like Nav1.5, not like Kir2.1 alone).\",\n      \"method\": \"Proximity ligation assay, patch-clamp, intracellular antibody dialysis, pharmacological inhibitors, co-immunoprecipitation\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods defining complex-specific regulation distinct from individual channel biology\",\n      \"pmids\": [\"29184507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Brugada syndrome-associated Nav1.5 trafficking-defective mutants decrease IK1 by failing to positively modulate Kir2.1/Kir2.2 channels. Golgi trafficking-defective Nav1.5 mutants additionally exert dominant-negative effects on Kir2.1/Kir2.2 and trap them, further reducing IK1. Conversely, ER trafficking-defective Nav1.5 can be partially rescued by Kir2.1/Kir2.2 via an unconventional GRASP-dependent secretory route.\",\n      \"method\": \"Mouse SCN5A haploinsufficiency models, heterologous expression, hiPSC-CM experiments, patch-clamp, immunostaining\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple model systems (mouse KO, heterologous cells, hiPSC-CMs), bidirectional trafficking relationship established\",\n      \"pmids\": [\"30232268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Kir2.1 promotes gastric cancer invasion and metastasis via a non-ion-conducting mechanism: it interacts with Stk38 kinase (confirmed by co-IP) to inhibit Smurf1-mediated ubiquitination and degradation of MEKK2, thereby activating the MEK1/2-ERK1/2-Snail pathway promoting EMT.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, overexpression, invasion/metastasis assays, ubiquitination assay, signaling pathway inhibitors\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP identifies Stk38 interaction, signaling pathway mechanistically validated, single lab\",\n      \"pmids\": [\"29549164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Kir2.1 function is required in cranial neural crest for craniofacial morphogenesis. In Xenopus, ATS-associated KCNJ2 mutations alter membrane voltage regionalization in ectoderm during neurulation and disrupt expression of craniofacial patterning genes. Optogenetic membrane potential manipulation in ectoderm during early neurulation is sufficient to cause craniofacial anomalies, identifying a bioelectric mechanism.\",\n      \"method\": \"Xenopus microinjection, optogenetics, voltage-sensitive dye imaging, in situ hybridization/immunostaining for patterning genes, Kcnj2KO mouse analysis\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — optogenetics with spatial and temporal control, multiple ATS mutations, KO mouse validation, multiple orthogonal approaches\",\n      \"pmids\": [\"26864374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Kir2.1 is required in cranial neural crest for palatal shelf proliferation and closure. Loss of Kir2.1 reduces BMP signaling efficacy (decreased phospho-Smad 1/5/8 and BMP target expression Smad6, Satb2) without altering BMP ligand, receptor, or Smad levels. Cdo forms a complex with Kir2.1 to promote surface expression during myogenic differentiation.\",\n      \"method\": \"Kcnj2 KO mice, conditional neural crest-specific knockout, BMP signaling analysis (Western blot for phospho-Smad), proliferation assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined signaling phenotype, multiple BMP pathway readouts, single lab\",\n      \"pmids\": [\"29571612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cdo forms a protein complex with Kir2.1 during myogenic differentiation and promotes Kir2.1 surface expression via p38MAPK signaling. Cdo depletion reduces Kir2.1 surface expression and channel activity; constitutively active MKK6(EE) rescues Kir2.1 activity in Cdo-depleted cells.\",\n      \"method\": \"Co-immunoprecipitation, surface expression assay, patch-clamp, siRNA knockdown, MKK6(EE) rescue, Cdo-/- primary myoblasts\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, functional rescue, and primary cell validation, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"27380411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Kir2.1-mediated membrane hyperpolarization controls macrophage nutrient acquisition by supporting cell-surface retention of nutrient transporters (4F2hc, GLUT1) through modulation of plasma membrane phospholipid dynamics. Loss of Kir2.1 induces caloric restriction state, activates AMPK and GCN2, depletes epigenetic substrates for histone methylation, and suppresses transcription of metabolism-responsive inflammatory genes.\",\n      \"method\": \"Genetic knockdown/knockout, pharmacological channel blockade, nutrient uptake assays, Ca2+ imaging, lipid/phospholipid analysis, epigenetic analysis, in vivo sepsis model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (genetic, pharmacological, metabolic, epigenetic), in vitro and in vivo validation, mechanistic pathway defined\",\n      \"pmids\": [\"35729093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Lysosome-mediated and ESCRT-mediated degradation control Kir2.1 surface levels; select α-arrestins (Ldb19/Art1, Aly1/Art6, Aly2/Art3) promote Kir2.1 trafficking to the cell surface and increase its activity via Rsp5 ubiquitin ligase and calcineurin effectors.\",\n      \"method\": \"Yeast synthetic gene array screen, fluorogen-activating protein fusion for surface quantification, functional complementation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide screen plus functional validation with novel surface quantification tool, single lab\",\n      \"pmids\": [\"29784874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SGK3 (serum/glucocorticoid-inducible kinase 3) upregulates Kir2.1-mediated currents and increases Kir2.1 protein abundance at the plasma membrane by promoting channel insertion (not reducing retrieval), as shown by similar brefeldin A-induced current decay with or without SGK3.\",\n      \"method\": \"Xenopus oocyte co-expression, two-electrode voltage-clamp, confocal imaging of membrane protein, brefeldin A trafficking assay\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct functional and surface expression assay, mechanism of insertion identified, single lab\",\n      \"pmids\": [\"23188060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Kir2.1 channel regulates macrophage M1 polarization via a Ca2+/CaMKII/ERK/NF-κB signaling pathway: Kir2.1-mediated membrane hyperpolarization drives Ca2+ influx, activating CaMKII/ERK/NF-κB; blocking Kir2.1 or high extracellular K+ suppresses M1 polarization and protects mice from LPS-induced peritonitis.\",\n      \"method\": \"siRNA knockdown, pharmacological blockade (ML133), Ca2+ imaging, Western blot for p-CaMKII/p-ERK/p-NF-κB, in vivo peritonitis model\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Ca2+ imaging links hyperpolarization to Ca2+ influx, signaling pathway validated biochemically, in vivo confirmation\",\n      \"pmids\": [\"35694964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Polyamine-induced rectification of Kir2.1 (IRK1) depends strongly on external K+ concentration (not internal K+): increasing external K+ speeds activation kinetics and shifts rectification proportional to EK shift. This establishes that permeant K+ ions modulate polyamine block kinetics in a long, narrow pore with multiple binding sites.\",\n      \"method\": \"Patch-clamp of Kir2.1-expressing Xenopus oocytes, varied internal and external K+ concentrations, polyamine block kinetics analysis\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic biophysical characterization, multiple polyamines and K+ concentrations tested, foundational mechanistic paper\",\n      \"pmids\": [\"8854340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Kir2.1 in endothelial cells (ECs) of mesenteric arteries amplifies endothelium-dependent vasodilatation. EC-specific Kir2.1 knockdown mice show reduced K+-induced and agonist/IK/SK-induced vasodilatations. The Kir channel blocker Ba2+ does not affect TRPV4, IK, or SK channel currents, establishing Kir2.1 as a downstream booster of the vasodilatory signal.\",\n      \"method\": \"EC-specific Kir2.1 conditional KO mice, patch-clamp, pressurized artery myography, pharmacological channel blockers\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple vasodilatory stimuli tested, pharmacological and genetic tools, clear pathway position established\",\n      \"pmids\": [\"26840527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Beta3-adrenoceptor activation increases Kir2.1 currents via PKC-dependent signaling (not PKA or CaMKII), while Kir2.2 is activated via PKA. This receptor-subtype-specific kinase pathway selectivity was established by kinase inhibitors and comparison of Kir2.2 mutants lacking PKC sites.\",\n      \"method\": \"Xenopus oocyte coexpression with human beta3-AR, two-electrode voltage-clamp, pharmacological kinase inhibitors, Kir2.2 PKC-site mutants\",\n      \"journal\": \"Naunyn-Schmiedeberg's archives of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic pharmacological dissection with receptor specificity controls, mutagenesis confirms Kir2.2 PKC site non-involvement, single lab\",\n      \"pmids\": [\"17534603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Zacopride selectively activates Kir2.1 homomeric channels via a PKA-dependent pathway in HEK293 cells. It does not affect Kir2.2 or Kir2.3 homomeric channels or Kir2.x heteromers. The effect is abolished by PKA inhibition and by the S425L mutation at the PKA phosphorylation site.\",\n      \"method\": \"Whole-cell patch-clamp in HEK293 cells transfected with Kir2.x, PKA inhibition, S425L mutagenesis\",\n      \"journal\": \"Science China. Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — mutagenesis of phosphorylation site and pharmacological inhibition define mechanism, single lab\",\n      \"pmids\": [\"23929001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Activated Ras (Ras-L61) reduces Kir2.1 (IRK1) current density by delocalizing the channel from the plasma membrane to the cytoplasm via the MAPK pathway; MEK inhibitor PD98059 restores membrane localization and current. This establishes Ras-MAPK pathway as a regulator of Kir2.1 subcellular localization.\",\n      \"method\": \"Heterologous expression in HEK293 cells, patch-clamp, confocal microscopy of GFP-IRK1, Northern blot, MEK inhibitor treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional and localization data with pharmacological rescue, two orthogonal methods, single lab\",\n      \"pmids\": [\"11809752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"KCNJ2/Kir2.1 promotes multidrug resistance in small-cell lung cancer by interacting with MRP1/ABCC1 (confirmed by co-IP) and is regulated by the Ras/MAPK pathway and miR-7.\",\n      \"method\": \"Co-immunoprecipitation, shRNA knockdown, overexpression, cell growth/apoptosis/drug resistance assays\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — co-IP identifies MRP1 interaction, functional consequences shown, but single lab and limited mechanistic follow-up of the interaction\",\n      \"pmids\": [\"25880778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Arg148 in the H5 pore domain of Kir2.1 (IRK1) serves as an external barrier for cationic blockers. Coexpression of R148H mutant with wild-type creates heteromeric channels with altered permeability ratios, increased Mg2+/Ca2+ sensitivity, and changed blocking kinetics. The R148 charge controls access of Mg2+ and Ca2+ to the electric field of the pore.\",\n      \"method\": \"Mutagenesis (R148H), Xenopus oocyte coexpression, single-channel recording, ion selectivity measurements, cation block analysis\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic mutagenesis with quantitative biophysical analysis of blocking kinetics, single-channel resolution\",\n      \"pmids\": [\"9382895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Kir2.1 inhibition in spinal microglia depolarizes their resting membrane potential, reduces proliferation after nerve injury, and attenuates neuropathic pain behaviors. Kir2.1 protein expression is increased at the plasma membrane of spinal microglia 2 days post-nerve injury, coinciding with peak proliferation.\",\n      \"method\": \"Patch-clamp, siRNA knockdown, ML133 pharmacological blockade, intrathecal injection in spared nerve injury model, immunofluorescence\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological inhibition with in vitro and in vivo phenotype, surface expression confirmed, single lab\",\n      \"pmids\": [\"32220118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"KCNJ2 inhibition potently mitigates neurodegenerative processes (neuronal death, tau phosphorylation, TDP-43 nuclear egress) after mechanical brain injury in iPSC-derived cortical organoids and in vivo, identified through genome-wide CRISPR interference screening.\",\n      \"method\": \"Genome-wide CRISPRi screen, iPSC-derived cortical organoids, ultrasound mechanical injury model, in vivo validation\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased genome-wide screen with in vitro and in vivo validation across multiple TBI hallmarks, single lab\",\n      \"pmids\": [\"38579683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The KCNJ2 promoter contains a minimal 172 bp TATA-less element driven by Sp1, Sp3, and NF-Y transcription factors at E box, Y box, and GC box elements. Upstream sequences restrict expression in a cell-type-dependent manner, identifying tissue-selective repressor elements.\",\n      \"method\": \"Promoter deletion analysis, transfection reporter assays, transcription factor co-transfection in cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic deletion analysis with transcription factor identification, two orthogonal methods, establishes minimal promoter mechanism\",\n      \"pmids\": [\"9712915\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNJ2/Kir2.1 is a strong inwardly rectifying K+ channel that forms homotetramers or heterotetramers with Kir2.2, Kir2.3, Kir2.4, or Kir5.1; its inward rectification is mediated by voltage-dependent block of the cytoplasmic pore by Mg2+ and polyamines (especially spermine), with the G-loop and di-aspartate cluster as structural determinants; channel gating and surface expression are regulated by PIP2 binding, PKA phosphorylation (at S425), PKC, tyrosine kinase phosphorylation (at Y242), AMPK (via Nedd4-2), PKB/PIKfyve, SGK3, and cholesterol/lipid raft partitioning; Kir2.1 is trafficked to the plasma membrane via a Golgi export YXXPhi motif, promoted by filamin-A and α-arrestins, and degraded via lysosomal and ESCRT pathways; in cardiomyocytes, Kir2.1 co-assembles with Nav1.5 early in the secretory pathway via AP1 adaptor, forming macromolecular complexes with distinct regulatory properties including CaMKII-dependent modulation; loss-of-function mutations cause Andersen-Tawil syndrome through dominant-negative or trafficking-defective mechanisms, while gain-of-function mutations cause Short QT Syndrome type 3; the channel also controls bioelectric membrane potential in macrophages (regulating inflammation via Ca2+/CaMKII/ERK/NF-κB) and in developing craniofacial ectoderm, and mediates K+-induced vasodilation in arterial smooth muscle and endothelium.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"KCNJ2 encodes Kir2.1, a strong inwardly rectifying potassium channel that sets resting membrane potential and shapes the terminal repolarization phase of the cardiac action potential, with broader roles in vascular tone, development, and immune cell function [#0, #1, #9]. Inward rectification is an intrinsic biophysical property requiring intracellular Mg2+ and voltage-dependent polyamine block within a long, narrow pore whose kinetics depend on permeant external K+; the H5 pore residue Arg148 controls cationic blocker access, while a cytoplasmic G-loop diffusion barrier and a distal di-aspartate cluster are structural determinants of rectification [#5, #11, #42, #48]. Channel gating and surface density are heavily regulated: PKA phosphorylation at S425 and PKC, tyrosine-kinase phosphorylation at Y242, AMPK (acting through Nedd4-2), SGK3, and cholesterol/lipid-raft partitioning all tune Kir2.1 activity and abundance [#10, #12, #13, #14, #20, #26, #40]. Forward trafficking proceeds through a C-terminal tyrosine-based YxxΦ Golgi-export motif and is promoted by filamin-A and α-arrestins, while degradation occurs via lysosomal, ESCRT, ERAD, and ubiquitin-proteasome routes [#4, #8, #28, #39]. In cardiomyocytes Kir2.1 pre-assembles with the sodium channel Nav1.5 at the trans-Golgi through the AP1 adaptor, forming a reciprocally trafficked macromolecular complex with distinct CaMKII- and 14-3-3-dependent regulation and Nedd4-2-mediated degradation [#31, #32, #33]. Loss-of-function KCNJ2 mutations cause Andersen-Tawil syndrome through dominant-negative co-assembly or trafficking-defective haploinsufficiency, whereas gain-of-function mutations that abolish inward rectification cause short QT syndrome type 3 and familial atrial fibrillation [#0, #3, #6, #7, #27, #29]. Beyond excitable tissue, Kir2.1 controls bioelectric membrane potential governing craniofacial neural-crest morphogenesis and BMP signaling, K+-induced vasodilation in arterial smooth muscle and endothelium, macrophage polarization and nutrient acquisition, and through non-conducting interactions promotes cancer invasion and drug resistance [#35, #36, #38, #41, #43, #34, #47].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that Kir2.1 inward rectification is not purely intrinsic to the protein but requires defined intracellular conditions, settling how the channel achieves voltage-dependent gating.\",\n      \"evidence\": \"Whole-cell and single-channel recording in MEL cells and giant inside-out patches with Mg2+, ATP, and kinase manipulation\",\n      \"pmids\": [\"8189383\", \"7993632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the polyamine blockers later shown to mediate rectification\", \"Structural basis of the Mg2+/ATP requirement not resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined how permeant ions and intracellular blockers cooperate to produce rectification, and identified specific kinase phosphorylation sites controlling channel activity.\",\n      \"evidence\": \"Patch-clamp polyamine block kinetics across K+ concentrations; PKA/PKC pharmacology and S425N mutagenesis in COS-7/tsA cells\",\n      \"pmids\": [\"8854340\", \"8650176\", \"8609894\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the pore structure accommodating multiple blocker binding sites\", \"Physiological receptor inputs driving phosphorylation in native tissue not fully mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Localized a specific pore residue (Arg148) acting as an external barrier governing cationic blocker and divalent access, refining the rectification mechanism at atomic resolution.\",\n      \"evidence\": \"R148H mutagenesis, single-channel recording, ion selectivity and block analysis in Xenopus oocytes\",\n      \"pmids\": [\"9382895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Charge effect inferred functionally without structure at the time\", \"Relationship to cytoplasmic blocker sites not integrated\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified an additional regulatory layer through tyrosine-kinase suppression at Y242 and characterized the basal transcriptional control of KCNJ2.\",\n      \"evidence\": \"Y242F mutagenesis with growth-factor receptor coexpression; promoter deletion and transcription-factor cotransfection assays\",\n      \"pmids\": [\"9852063\", \"9712915\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of growth-factor suppression in heart/muscle unquantified\", \"Tissue-selective repressor elements not molecularly identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated through genetic knockout that Kir2.1 is required for inward rectifier currents and K+-induced vasodilation in arterial smooth muscle, establishing a physiological role outside cardiac excitability.\",\n      \"evidence\": \"Kir2.1-/- mice, myocyte patch-clamp, pressurized cerebral artery dilation\",\n      \"pmids\": [\"10904001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endothelial versus smooth-muscle contribution not separated at this stage\", \"Downstream coupling to dilatory effectors not defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified KCNJ2 as the causative gene for Andersen's syndrome and showed mutations act through loss-of-function with dominant-negative suppression, defining the disease mechanism.\",\n      \"evidence\": \"Genetic mapping and two-electrode voltage-clamp of mutants in Xenopus oocytes; AKAP79 co-IP/pulldown linking PKA anchoring\",\n      \"pmids\": [\"11371347\", \"11287423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not distinguish trafficking versus assembly defects among mutations\", \"Tissue-specific phenotype variability unexplained\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Connected reduced Kir2.1 current to specific arrhythmogenic action-potential changes and broadened the picture with subtype heteromerization, subcellular distribution, and Ras-MAPK regulation.\",\n      \"evidence\": \"Voltage-clamp of 10 ATS mutants with computational myocyte modeling; Kir2.4 co-assembly pulldowns; cardiomyocyte immunocytochemistry; Ras-L61/MEK-inhibitor localization studies\",\n      \"pmids\": [\"12163457\", \"12148092\", \"12381809\", \"12181143\", \"11809752\", \"12045162\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heteromer stoichiometry in native tissue not quantified\", \"Mechanistic link between MAPK and trafficking machinery incomplete\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved that distinct ATS mutations cause dysfunction by mechanistically separable routes — dominant-negative co-assembly, trafficking failure, or haploinsufficiency — and identified filamin-A as a trafficking-promoting partner.\",\n      \"evidence\": \"HEK293 patch-clamp with confocal/FRET trafficking analysis of multiple mutants; yeast two-hybrid, reciprocal pulldown, and co-IP for filamin-A\",\n      \"pmids\": [\"14522976\", \"12689820\", \"12923176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants selecting which mutation follows which route not predictive\", \"Filamin-A interaction interface not mapped to atomic detail\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Provided structural grounding for rectification via the cytoplasmic G-loop and di-aspartate cluster, and established that gain-of-function mutations produce a clinically distinct short-QT/atrial-fibrillation phenotype.\",\n      \"evidence\": \"X-ray crystallography of cytoplasmic domains with mutagenesis; D172N and V93I gain-of-function patch-clamp with ventricular modeling; YxxΦ Golgi-export chimera analysis\",\n      \"pmids\": [\"15723059\", \"15761194\", \"15922306\", \"15827083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length channel structure in membrane not solved\", \"How export motif sets heteromer surface stoichiometry mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Pinpointed the G-loop residue V302 as critical for both K+ conduction and PIP2 gating, linking a trafficking-normal ATS mutation directly to a permeation defect.\",\n      \"evidence\": \"Systematic V302 substitution mutagenesis with patch-clamp, surface assays, and structure-guided interpretation\",\n      \"pmids\": [\"17166852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coupling between PIP2 binding and G-loop conduction not kinetically dissected\", \"T192 PIP2-site contribution addressed separately and incompletely\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established kinase-controlled degradation by showing AMPK reduces Kir2.1 surface abundance through Nedd4-2, embedding the channel in metabolic-stress signaling.\",\n      \"evidence\": \"Xenopus oocyte coexpression, voltage-clamp, confocal surface imaging, Nedd4-2 S795A mutagenesis\",\n      \"pmids\": [\"21501591\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Kir2.1 ubiquitination by Nedd4-2 not demonstrated here\", \"Native-tissue relevance not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapped the degradation and surface-trafficking machinery (lysosome, ESCRT, ERAD, α-arrestins) and characterized additional gain-of-function mutations disrupting rectification through heteromerization.\",\n      \"evidence\": \"Yeast synthetic gene array screens with human-cell validation and surface-quantification fusions; E299V patch-clamp, co-IP, and modeling; zacopride PKA-dependent activation via S425\",\n      \"pmids\": [\"24227888\", \"29784874\", \"23440193\", \"23929001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative flux through ESCRT versus ERAD in native cardiomyocytes unknown\", \"Mammalian orthologs of α-arrestin effects not fully validated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected charge-dependent loss of rectification to disease and showed SQT3 mutations gain function additionally by altering ubiquitylation, lipid-raft partitioning, and caveolin interactions.\",\n      \"evidence\": \"M301K/R/A mutagenesis with cardiomyocyte overexpression; ubiquitylation, raft fractionation, caveolin co-IP, and patch-clamp\",\n      \"pmids\": [\"22155372\", \"24794859\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether stability and conduction changes are mechanistically coupled unresolved\", \"Caveolin-1 versus caveolin-2 functional division not fully defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealed a non-excitable, bioelectric role for Kir2.1 in craniofacial development and identified Cdo/p38MAPK as a trafficking-promoting axis in myogenesis.\",\n      \"evidence\": \"Xenopus optogenetics, voltage-dye imaging, ATS-mutation expression, Kcnj2 KO mouse analysis; Cdo co-IP, surface assays, MKK6(EE) rescue in primary myoblasts\",\n      \"pmids\": [\"26864374\", \"27380411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How membrane voltage is transduced to patterning-gene expression mechanistically unclear\", \"Cdo interaction interface not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the cardiac Kir2.1-Nav1.5 macromolecular complex — co-trafficked from the trans-Golgi via AP1 and reciprocally regulated — establishing channel interdependence relevant to both ATS and Brugada syndrome.\",\n      \"evidence\": \"Co-IP, FRAP, biotinylation, AP1 silencing in hiPSC-CMs; SCN5A haploinsufficient mice and hiPSC-CMs with trafficking-defective Nav1.5 mutants; PLA and CaMKII/14-3-3 inhibitor analysis\",\n      \"pmids\": [\"29514831\", \"30232268\", \"29184507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the channelosome unresolved\", \"GRASP-dependent unconventional rescue route mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated a conduction-independent oncogenic function of Kir2.1, scaffolding kinase signaling to drive EMT, invasion, and drug resistance in cancer.\",\n      \"evidence\": \"Co-IP of Stk38 and MRP1, knockdown/overexpression, ubiquitination assays, and invasion/drug-resistance assays in gastric and small-cell lung cancer\",\n      \"pmids\": [\"29549164\", \"25880778\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct versus indirect nature of interactions not fully resolved\", \"In vivo tumor relevance limited to single labs\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended Kir2.1 into immunometabolism, showing its hyperpolarizing current controls macrophage polarization and nutrient transport, linking membrane bioelectrics to inflammatory and metabolic programs.\",\n      \"evidence\": \"Genetic and pharmacological inhibition, Ca2+ imaging, phospholipid and epigenetic analysis, in vivo sepsis/peritonitis models\",\n      \"pmids\": [\"35729093\", \"35694964\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular sensor coupling hyperpolarization to transporter retention not defined\", \"Whether channel conduction or scaffolding dominates not separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified Kir2.1 as a tractable node in neural injury, where its inhibition mitigates neurodegenerative hallmarks after mechanical brain injury.\",\n      \"evidence\": \"Genome-wide CRISPRi screen in iPSC cortical organoids with ultrasound injury and in vivo validation; prior microglial Kir2.1 work in neuropathic pain\",\n      \"pmids\": [\"38579683\", \"32220118\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking Kir2.1 activity to tau phosphorylation and TDP-43 mislocalization unknown\", \"Cell-type contribution (neuron vs glia) not separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How Kir2.1's conducting and non-conducting (scaffolding/bioelectric) functions are partitioned across tissues, and how membrane voltage is mechanistically transduced into developmental, immune, and signaling outputs, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking ion conduction to scaffolding functions\", \"Signal transduction from membrane potential to gene-expression programs undefined\", \"Full-length membrane-embedded structure with regulatory partners not solved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 9, 11, 42, 48]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [20, 21, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [16, 18, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 17, 20]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [8, 31]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [24, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [49, 50]},\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [37]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [35, 36]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [38, 41]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [8, 31, 39]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 6, 23]}\n    ],\n    \"complexes\": [\n      \"Kir2.1-Nav1.5 channelosome\",\n      \"Kir2.x heterotetramers (Kir2.4, Kir5.1)\"\n    ],\n    \"partners\": [\n      \"FLNA\",\n      \"AKAP5\",\n      \"KCNJ16\",\n      \"KCNJ14\",\n      \"SCN5A\",\n      \"NEDD4L\",\n      \"STK38\",\n      \"CDON\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}